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Abstract 
 
 
Bacteria possess multiple resistance mechanisms, but little is known why one 
mechanism can be favoured over others. With a focus on two resistance 
mechanisms of the pathogenic bacteria Pseudomonas aeruginosa, I expand on 
present knowledge by looking at ecological and genetic selection pressures that 
drive the adaptive resistance mechanism of the CRISPR-Cas (Clustered Regular 
Interspaced Short Palindromic Repeats – CRISPR associated) system compared 
with general resistance through cell surface modification. Specifically, I show that 1) 
the evolution of CRISPR-Cas immunity is not general across all phage species. 2) I 
examine how adaptive evolution is affected when a phage species, known to elicit 
CRISPR-Cas evolution, is mixed with novel phage species and demonstrate that the 
resistance mechanism is switched in combination with multiple phages, to surface 
modification. 3) I show how priming is important for continued resistance when 
phage have escaped the CRISPR-Cas system. However, significant detection of 
priming may vary between different host-phage interactions. 4) I then show how 
primed bacterial strains fail to evolve CRISPR-Cas resistance when infected with 
phage mixtures, even though prior spacer acquisition exists. 5) Finally, the benefit of 
the CRISPR-Cas system in generating genetic diversity is shown to rapidly clear 
phage from the environment. Combined, these results show that, even though there 
are substantial fitness benefits associated with CRISPR-Cas immunity, P. 
aeruginosa will develop resistance by means of surface modification in the face of 
phage diversity. 
 
 
 
 
 
 
 
 
 
 
 
 
  3  
  
Acknowledgements 
 
 
I whole heartedly thank my brilliant supervisors for their advice, guidance and 
support throughout this Masters. I am extremely grateful to Professor Angus 
Buckling for getting me interested in evolutionary ecology in the first place and to Dr 
Edze Westra for the endless support and encouragement. Thank you both for giving 
me the freedom to try out new and exciting things but always being there to steer me 
in the right direction. It’s been a fantastic experience and I hope I can continue to 
work with you both in the future. 
 
A special thanks to Dr. Stineke van Houte whose cheery disposition made long days 
less tedious and whose help was always at hand and enthusiastically given.  
 
I have been so lucky to be surrounded by the ever-growing, changing and brilliant 
Buckling lab group of Elze Hesse, Siobhan O’Brien, Adela Lujan, Florian Bayer, 
Andrea Dowling, Suzanne Kay, Pawel Sierocinski, Peter Stillwell, Sean Meaden, 
Nicole Parr, Lewis Campbell, Jenny Broniewski, Dan Morley, Helene Chabas, Iris 
van der Zande, Loris Capria, Mhairi Inglis and Daniella Farina.  
 
And I could not have finished this thesis without the help of Olivia Lee whose endless 
supply of tea helped keep me going and remain somewhat sane. Also to “The A 
Team”: Abigail Colclough, Aimee Murray and Amy McLeman for the unwavering 
support, encouragement and laughs along the way.  
 
 
And finally I thank the University of Exeter for putting up with me for all these years. 
 
 
 
 
 
 
 
 
 
 
  4  
  
Table of Contents 
 
 
Abstract …………………………………………………………………………………….. 2 
 
Acknowledgements ……………………………………………………………………….. 3 
 
List of tables and figures ………………………………………………………………….. 5 
 
Abbreviations ………………………………………………………………………………. 8 
 
Foreword …………………………………………………………………………………… 9 
 
Introduction ……………………………………………………………………………….. 10 
 
 
Chapter: 
 
1. How general is the evolution of CRISPR-Cas resistance across single 
bacteriophage infections of the bacteria Pseudomonas aeruginosa? .......... 18            
 
2. The effects of multiple bacteriophages on the evolution of resistance in the 
bacteria Pseudomonas aeruginosa ……………………………………………. 36 
 
3. The importance of priming in CRISPR-Cas mediated resistance…………… 47 
 
4. The effects of primed multiple bacteriophages on the evolution of 
resistance………………………………………………………………………….. 61  
 
5. The diversity-generating benefits of an adaptive immune system…………... 72 
 
 
General discussion ………………………………………………………………………. 88 
 
Appendix …………………………………………………………………………............. 91 
 
Bibliography ………………………………………………………………...…………… 104 
 
 
 
 
 
 
 
 
 
 
 
 
 
  5  
  
List of tables and figures 
 
 
Introduction 
 
Figure 1: An overview of the phage lytic cycle 
Figure 2: Diagram of bacterial defence systems 
Figure 3: Diagram of Pseudomonas aeruginosa PA14 CRISPR-Cas locus  
Figure 4: Mechanistic overview of the process of the CRISPR-Cas system 
 
 
Chapter 1  
 
Table 1: Phages used in experimental procedures 
 
Figure 1: Average fraction of CRISPR-Cas resistance, sm mediated resistance and 
sensitive cells in different phage treatments at 19dpi 
Figure 2: Average fraction of CRISPR-Cas resistance, sm mediated resistance and 
sensitive cells in different phage treatments under daily phage infections at 19dpi 
Figure 3: Relative fitness of CRISPR versus sm mediated resistance  
Figure 4: Competition assay of BIM-LPB1 in different nutrient limiting conditions 
 
 
Chapter 2 
 
Figure 1: Average fraction of CRISPR-mediated resistance versus sm-mediated 
resistance in treatments containing multiple pilus-binding phages at 3dpi 
Figure 2: Average fraction of CRISPR-mediated resistance versus sm-mediated 
resistance in multiple LPS-binding phage treatments at 3dpi 
Figure 3: Cross-resistance in multiple LPS-binding phage experiments 
 
 
 
 
  6  
  
Chapter 3 
 
Table 1: BIMs and escape phages used in experimental procedures 
 
Figure 1: Average fraction of resistance (CRISPR or sm-mediated) or sensitivity in 
evolution experiments with WT or CRISPR knockout strains in the presence of 
phage DMS3vir at 3dpi 
Figure 2: P. aeruginosa PA14 (WT) and primed strains; BIM68-1 and BIM68-2 at 
3dpi of phage 68 
Figure 3: Diagram of partial match of spacer 1 on the CRISPR2 locus to DMS3vir  
 
 
Chapter 4 
 
Table 1: BIMs and escape phages used in experimental procedures 
 
Figure 1: Average fraction of P. aeruginosa strain PA14 (WT) population immunity 
and sensitivity at 3dpi  
Figure 2: Average fraction of bacterial strain BIM68-1 population immunity and 
sensitivity at 3dpi  
Figure 3: Average fraction of bacterial strain BIM68-2 population immunity and 
sensitivity at 3dpi 
 
 
Chapter 5 
 
Figure 1: Evolution of CRISPR-mediated immunity leads to rapid extinction of virus 
Figure 2: Virus persistence inversely correlates with the level of spacer diversity 
Figure 3: Relative fitness of bacterial populations with CRISPR-mediated immunity 
positively correlates with increasing spacer diversity 
Figure 4: Emergence of virus that overcomes host CRISPR immunity (escape virus) 
during the experiment shown in Figures 2 and 3 
 
  7  
  
Appendix: Extended data of Chapter 5 
 
Extended Data Table 1: Tukey HSD all pairwise comparisons of the data in Figure 3 
 
Extended Data Figure 1: Infection with virus DMS3vir leads to rapid evolution of 
CRISPR-mediated immunity in WT bacteria, while CRISPR KO bacteria primarily 
evolve virus immunity by surface mutation 
Extended Data Figure 2: No benefit of increasing spacer diversity in the absence of 
virus 
Extended Data Figure 3: Deep sequencing analysis of the frequency of mutations in 
the target sequence of virus isolated at t=1 from the experiment shown in Figure 4 
Extended Data Figure 4: Escape virus titres decline upon infection of diverse 
CRISPR populations despite increased fitness over ancestral virus 
Extended Data Figure 5: Diverse populations do not acquire additional spacers 
during the experiments shown in Figures 2-4  
Extended Data Figure 6: Persistence of phage that encodes an anti-CRISPR gene is 
independent of spacer diversity 
Extended Data Figure 7: Virus persistence inversely correlates with the level of 
CRISPR spacer diversity in CRISPR immune populations of Streptococcus 
thermophilus  
Extended Data Figure 8: Sensitive bacteria are unable to invade bacterial 
populations with CRISPR-mediated immunity in the presence of virus 
Extended Data Figure 9: Virus persistence inversely correlates with the level of 
CRISPR spacer diversity during competition between CRISPR immune populations 
and the sensitive CRISPR KO strain 
Extended Data Figure 10: Emergence of virus mutants that overcome CRISPR-
mediated immunity during the experiment shown in Extended Data Figure 9 
Extended Data Figure 11: Sensitive bacteria are unable to invade bacterial 
populations with CRISPR-mediated immunity in the absence of virus, independent of 
the level of spacer diversity 
 
 
 
  8  
  
Abbreviations 
 
CRISPR-Cas Clustered Regular Interspaced Short Palindromic Repeats – 
CRISPR associated 
sm   surface mutant 
dpi   days post infection 
LPS   Lipid polysaccharide  
WT    Wildtype bacterial strain 
pfu   plaque forming unit 
cfu   colony forming unit 
rtp   room temperature and pressure 
rpm   rounds per minute 
BIM   Bacteriophage-Insensitive Mutant 
CRISPR KO  CRISPR Knock-out strain (also referred to as csy3::LacZ) 
hpi   hours post infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  9  
  
Foreword 
 
Chapter 5 was the result of a collaborative effort and is currently in press. I helped to 
perform almost all laboratory experiments and aided in the editing of the manuscript. 
The title and joint authors are as follows; 
 
van Houte, S., Ekroth, A.K.E., Broniewski, J.M., Chabas, H., Ashby, B., Bondy-
Denomy, J., Gandon, S., Boots, M., Paterson, S., Buckling, A.J. and Westra, E.R. 
(Nature, In Press) The diversity-generating benefits of an adaptive immune system. 
 
 
Reviews of the literature are provided and each topic discussed in each chapter. A 
general overview of the CRISPR-Cas system is given in the thesis introduction. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  10  
  
Introduction 
 
Antagonistic coevolution is the result of host-parasite interactions where parasite 
infection selects for host resistance which then selects for increased parasite 
virulence (Thompson 1994). This endless arms race of host adaptations and parasite 
counter-adaptations play an important role in shaping host-parasite population 
dynamics. It is therefore vital to understand how different selective pressures, such 
as different environmental conditions or different within and between species 
interactions, drive the evolution of defence and counter-defence mechanisms. The 
defensive mechanisms of evolved immunity elicited, in the host, as a response to 
these interactions will be the foundation of the experiments described in this thesis. 
 
Bacteriophages (parasites) are phages that infect bacteria (host) by injecting their 
genetic material into the hosts’ cells. To do so, the phage must target and bind to 
receptors on cell surfaces. Once inside the host, phages will replicate by exploiting 
the bacterial cell’s cellular functions, and then burst out by means of cell lysis (Figure 
1) (Buckling & Rainey 2002). In order to cope with this continuous threat of infection, 
bacteria have developed various defence mechanisms (Figure 2), all of which can be 
categorised into extracellular and intracellular defences. Extracellular defences 
enable the bacterium to inhibit phage adsorption and block their uptake via cell 
surface modifications by losing, mutating or masking phage receptors. Intracellular 
defences, on the other hand, will cleave the DNA of these invaders by the means of 
either the restriction-modification (R-M) system or the CRISPR-Cas (Clustered 
regularly interspaced short palindromic repeats – CRISPR associated) system once 
phages manage to inject their genome into a bacterial cell. Alternatively, bacterial 
cells can act altruistically, through abortive infection, where cell death results in 
infection failure, and thus prevents phage proliferation and subsequent spread 
through the host population. 
 
The evolution of these bacterial defence mechanisms can be a slow process. For 
example, the R-M system, containing the enzymes methyltransferase and restriction 
endonuclease, will target and modify foreign invader DNA within the bacterial cell. As 
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modification of foreign DNA requires specific point mutations in the targeted 
sequence, this process is often slow. The release and subsequent re-infection of the 
same invader will then be subdued as the restriction endonuclease will cleave the 
targeted sequence (Westra et al. 2012).  
 
There are, however, two defence mechanisms that adapt rapidly to novel phages 
and can be studied in real-time laboratory evolution experiments. Surface 
modification (sm) is quick and provides bacterial hosts with phage immunity by 
altering the cell surface receptors. The other is the CRISPR-Cas system which 
defends the host by integrating invader DNA into its own genome, allowing the host 
to recognise an invader upon infection.  
 
This thesis endeavours to understand the ecological factors that drive the evolution 
of sm and CRISPR-Cas mediated resistance of the pathogenic bacteria 
Pseudomonas aeruginosa strain PA14 to its bacteriophage parasites. The studied 
bacterium has a type IF CRISPR-Cas system that consists of six cas genes that are 
flanked by two CRISPR arrays (Figure 3). Resource limited conditions have 
previously shown the evolution of P.aeruginosa PA14 CRISPR-Cas immunity against 
phage DMS3vir (Westra et al. 2015), a mu-like phage that infects by binding to the 
bacterial pilus (Cady & O’Toole 2011). I use the experimental system of 
P.aeruginosa and its bacteriophage parasites to understand whether the CRISPR-
Cas evolution observed for DMS3vir by the Westra et al. (2015) study is general 
across bacteriophage infections (Chapter 1). Following this, I look at the effects of 
multiple bacteriophage exposure on the evolution of defence mechanisms (Chapter 
2). I then look at the pre-requisites of the adaptive function of CRISPR-Cas system in 
a novel system (Chapter 3) and a multiple bacteriophage system (Chapter 4). 
Finally, the co-evolutionary dynamics associated with CRISPR-Cas are explored in 
Chapter 5. 
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The history, molecular mechanism and applications of the CRISPR-Cas system 
 
History 
As an adaptive immune system, CRISPR-Cas provides acquired resistance to 
phages and plasmids. The CRISPR-Cas system itself was first discovered in 1987 
by Ishino and colleagues, when localised repeat sequences were found within the 
genome of Escherichia coli (Ishino et al. 1987). These repeat sequences were 
shown to be adjacent to variable sequences, known today as spacers. However, it 
was not until 2005 that these spacer sequences were shown to be derived from 
foreign genetic elements (Bolotin et al., Mojica et al. & Pourcel et al. 2005). Later, in 
2007, Barangou and colleagues demonstrated, in Streptococcus thermophilus, that 
spaces are acquired in response to phage infection thereby providing host immunity 
(Barrangou et al. 2007). Their study demonstrated that, by removing resistance-
conferring acquired spacers, once resistant bacteria became phage-sensitive. Then, 
by inserting the phage resistant spacer into the CRISPR array of sensitive bacteria, 
these sensitive bacteria in turn became resistant. This was the first demonstration of 
CRISPR-Cas working as an immune defence system. Furthermore, as past phage 
infections are recorded in the form of spacers, these sequences provide a molecular 
memory of past bacteriophage infections, where unique spacer-phage recognitions 
allow the host to defend itself upon phage re-infections (Datsenko et al. 2012, Vale 
2010). 
 
Mechanism 
Our understanding of the CRISPR-Cas system improves as research is pinning 
down the processes involved in spacer incorporation. CRISPR arrays (repeat-spacer 
units), along with Cas proteins, form the adaptive immune system, known as 
CRISPR-Cas, and works as follows: 1) Upon viral infection, the bacterial Cas 
complex identifies alien DNA. 2) It will then incorporate, at the leader end, a unique 
repeat-spacer unit to the CRISPR locus (Figure 4). The leader is a sequence located 
on the 5’ end of most CRISPR loci and can be considered as a recognition sequence 
because new repeat-spacer units are often added on adjacently (Sorek et al. 2008). 
3) The novel repeat-spacer unit will then be transcribed into pre-crRNA and 
processed into mature crRNAs (Brouns et al. 2008) by Cas proteins, which use 
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these mature crRNAs as guides to detect (Jore et al. 2011) and cleave 
complementary invading nucleic acid (Garneau et al. 2010), which results in the 
failed infection and subsequent clearance of the parasite.  
 
 
Applications 
The possible benefits arising from this adaptive immune system have generated 
research into its application in 1) the development of antimicrobials, where the use of 
Cas nucleases can target and reprogram antibiotic resistance genes in bacterial 
populations to prevent the spread of antibiotic resistant individuals (Bikard et al. 
2014), 2) uses in industry, whereby genetically engineered bacteriophage resistant 
mutants are able to provide a starter bacterial population with increased immunity 
against known phage (Sturino & Klaenhammer 2006) and 3) uses in genome editing, 
where a modified CRISPR-Cas system can be adapted to adjust or repair an 
organism’s genome (Hwang et al. 2013). 
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Figure 1: An overview of the bacteriophage lytic cycle. Image taken from Labrie et 
al. (2010) 1) Infection is initiated by phage adsorption through a known receptor on 
the host cell wall. 2) Once successful attachment has occurred, phage DNA enters 
the cell. 3) Phage DNA then replicates inside the cell. 4) Phage then exploits 
bacterial cell mechanisms in order for its DNA to be transcribed and translated into 
new progeny. 5) After the successful transcription and translation of phage DNA, 
new phage particles assemble. 6) Phages burst from the bacterial cell, by means of 
lysis, where the infection process of a new bacterial cell can take place. 
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Figure 2: Diagram of bacterial defence systems. Image taken from Westra et al. 
(2012). From left to right; Phage adsorption or DNA injection may be blocked by 
masking or mutation of surface receptors. The self-sacrifice altruistic behaviour of 
abortive infections involves cell death upon infection. Phage injection may also be 
blocked by surface receptors (Uptake block). Restriction modification (R-M) systems 
will modify foreign DNA with the enzyme methyltransferase (M) and restriction 
endonuclease (R) will cleave the foreign DNA sequence. The CRISPR-Cas 
(Clustered Regularly interspaced palindromic repeats – CRISPR associated) system 
integrates foreign DNA (Blue phage) into the host genome and as a consequence, is 
recognised and cleared from the host. 
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Figure 3: Diagram of Pseudomonas aeruginosa PA14 CRISPR-Cas locus. The 
defence system contains two CRISPR loci, where CRISPR 1 contains 14 spacers 
and CRISPR 2 contains 21 spacers. There are six distinct Cas genes, which are 
located between loci, and are termed cas1, cas3, csy1, csy2, csy3, and cas6f. Image 
taken from Westra et al. (2015). 
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Figure 4: Mechanistic overview of the process of the CRISPR-Cas system. Modified 
from Sorek et al. (2008). a) Simplified structure of a CRISPR locus. b) Diagram of 
the outcomes of phage attack. Once successful attachment has occurred, the phage 
is able to inject itself into the cell. Phage particles then proliferate. In one instance, 
cell death occurs, in the other, bacteria integrate phage-derived spacers (marked by 
an asterisk) into its genome and survive. c) CRISPR mechanism overview. Once 
phage genetic information has been incorporated, in the form of a spacer, into the 
bacterial genome, the repeat-spacer unit is transcribed into RNA. Cas proteins, 
recognising the repeat sequences, process the RNA into small RNAs (sRNAs). 
Phage degradation and removal can then occur as sRNAs and Cas proteins base 
pair to phage mRNA.  
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Chapter 1 
 
How general is the evolution of CRISPR-Cas resistance across single 
bacteriophage infections of the bacteria Pseudomonas aeruginosa?  
 
Abstract 
 
The pathogenic bacteria Pseudomonas aeruginosa strain PA14 can evolve 
resistance to bacteriophage (phage) by surface modification (sm) or by using the 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats – 
CRISPR associated) adaptive immune system. In a study with P. aeruginosa and its 
phage DMS3vir, it was reported that CRISPR-Cas immunity evolves in nutrient 
limited conditions and sm in nutrient rich conditions, due to associated inducible and 
constitutive fitness costs. Here I investigate the generality of the evolution of the 
CRISPR-Cas defensive response in nutrient limited conditions by using a diverse 
phage collection. In contrast to results with phage DMS3vir, I found that almost all 
phages trigger the evolution of sm immunity. Interestingly, the relative benefits of 
CRISPR-Cas differed between phages that target different receptors. However, 
CRISPR-Cas failed to evolve even when it provided a fitness benefit to sm. This 
suggests that factors other than fitness costs and benefits determine the evolution of 
adaptive immunity in bacteria.   
 
1. Introduction 
 
The impact of parasites on host evolution can be affected by whether or not there is 
single or multiple parasite species interacting with the host. Indeed, in a snail - 
trematode system where the snail hosts can select to reproduce sexually or 
asexually, different parasitic trematode infections were shown to cause variation in 
the frequency of sexual individuals of host populations (King & Lively 2009). In three-
spined sticklebacks (Gasterosteus aculeatus), the diversity of the major 
histocompatibility complex (involved in resistance) varied between host populations 
of different habitats as the result of simultaneous infections made by different 
combinations of parasite species (Wegner et al. 2003). In another system, ants 
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infected by multiple parasites have developed a hierarchical host defence strategy 
where each individual parasite was dealt with separately depending on cost to host 
fitness (von Beeren et al. 2011). Thus, the evolution of host resistance varies in 
different host-parasite systems and can depend on single or multiple parasite 
infections. 
 
Phage infections are ubiquitous in nature, and consequently, cause bacterial host 
defence strategies to evolve. The most common strategies are; surface modification 
(sm), which involves the loss, masking, or mutation of cell surface receptors; and 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats – 
CRISPR associated) which provides host resistance by integrating phage derived 
sequences, termed spacers, into the host genome (van der Oost et al. 2014, Levin et 
al. 2013, Swarts et al 2012). The homologous nature of these spacer sequences to 
phage DNA enables the bacteria to quickly recognise and clear phage infection. In 
response, phages can escape CRISPR-Cas by point mutation in the cognate 
sequence (Datsenko et al. 2012). The adaptive process of the CRISPR-Cas system 
allows immunity to be continuously renewed and can therefore be used as a model 
system to study the evolution of resistance in host-parasite dynamics. 
 
In a recent study by Westra et al. (2015), it was shown that resource availability 
greatly influenced the defence mechanism evolved upon parasite exposure. It was 
demonstrated that, in resource abundant environments, bacterial immunity was 
favoured by means of sm. By contrast, in resource scarce environments, bacterial 
immunity was achieved through the CRISPR-Cas system. It was hypothesized that 
the different environmental conditions caused different infection risks. Reduced 
bacterial growth, caused by low resources, meant that phage infection risk was lower 
as host-phage encounters were fewer. The pressure of varying infection risk was 
thus believed to affect the relative investment in either sm-mediated resistance or 
CRISPR-Cas mediated resistance. The results of the study conducted by Westra et 
al. (2015) showed clear host evolution by means of CRISPR-Cas resistance in the 
experimental system of Pseudomonas aeruginosa and its phage DMS3vir. However, 
this study was performed using the limited range of one phage species. 
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Here I examine the generality of this observation by challenging P. aeruginosa with 
other phage species and examine the evolution of sm and CRISPR-Cas defences in 
the bacterial host.  
 
 
2. Materials and Methods 
 
2.1 Bacterial strains, phages and experimental conditions  
Bacteria 
Pseudomonas aeruginosa PA14 wild type (WT) and PA14 csy3::LacZ (LacZ) were 
supplied by the O’Toole lab (Cady & O’Toole 2011) at the Geisel School of Medicine 
(Hanover, New Hampshire, USA). Strains were grown at 37°C throughout 
experimental procedures. Two PA14 LacZ derived surface modification (sm) 
mutants, one with no pilus (sm1) and the other with modified LPS (Lipid 
polysaccharide) sites (sm2), were used in competition assays. These sm mutants 
were procured in evolution experiments with LacZ cells and phage DMS3vir (sm1) or 
phage LPB1 (sm2). The bacteriophage-insensitive mutant (BIM) BIM-4 was obtained 
through an evolution experiment with WT PA14 and phage DMS3vir, and contains 
one novel spacer targeting DMS3vir.  
 
Bacterial growth media 
Bacterial growth media consisted of M9 salts (60g of Na2HPO4.7H2O, 30g of 
KH2PO4, 10g of NH4Cl and 5g of NaCl) which were supplemented with 1mM of 
MgSO4, 0.1 mM of CaCl2 and 0.2% glucose. CRISPR mediated resistance has 
previously been shown to occur under these nutrient limiting conditions in response 
to phage DMS3vir and was thus chosen for this study (Westra et al. 2015). In order 
to isolate single colonies, bacterial cultures were plated onto LB (Luria-Bertani) 1.5 
% agar (Miller, Molecular Genetics Powder, Fisher Scientific). The formula per Liter 
contained: 10g Tryptone, 5g Yeast Extract, 10g Sodium Chloride and 15g Agar. 
  21  
  
 
Phages 
Selections of lytic phages, that are either pilus or LPS specific, are listed in (Table 1). 
Pilus mediated phage infection was verified by pipetting selected phage onto ΔpilA 
(a pilus knockout bacterial strain) bacterial lawns. 
  
Preparing phage stocks 
Phage stock solutions were prepared by adding 10µL of 106 pfu (plaque forming 
units) /mL of desired phage to 300µL of overnight grown LacZ cells into 0.5% LB 
agar. Once mixed, the 0.5% LB agar supplemented with phage and bacteria, was 
poured onto prepared plates of 1.5% LB agar. Near confluent lysis (NCL) was 
determined from plates incubated overnight. Whereupon, plates were flooded with 
10mL M9 salts and left at r.t.p (room temperature and pressure) for two hours to 
allow phage and bacteria to dissolve into the salt solution. The liquid mixture was 
then pipetted off of the plates into Falcon tubes. Falcon tubes were centrifuged at 
35000 rpm (rotations per minute) for 10 minutes. Supernatant was transferred into 
new Falcon tubes, where a chloroform extraction, followed by further centrifugation, 
was conducted to kill any remaining bacterial cells. Phage titrations were performed 
as described below and stock solutions were stored at 4°C. 
 
Phage titration 
Chloroform extractions were performed on phage solutions, whereby 100µL 
chloroform (10%) was added to 900µL of each sample replicate. Phage titres were 
determined by serially diluting phage solutions in M9 salts. 5µL of virus at 10-fold 
dilutions were spotted onto 1.5% LB agar containing a bacterial lawn top layer. 
Bacterial lawns were made by mixing 300µL of LacZ cells (phage sensitive bacteria) 
with 9mL 0.5% LB agar layer. After overnight incubation at 37°C, plaques were 
counted to determine phage titre. 
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2.2 Streak assays 
Upon experimental conclusions, replicate populations were diluted and plated onto 
1.5% LB agar. A total of 16 single isolated colonies per replicate were selected and 
grown overnight in 0.2% glucose M9 media. Overnight cultures were streaked across 
a horizontal line of 25µL of a given phage at 1 x 109 pfu/mL. Resistance was 
determined when bacteria showed no growth inhibition, while sensitivity was 
determined as inhibition of growth across the line of phage.  
 
2.3 Spacer acquisition 
Once stocks of single colonies had been obtained, they were diluted 10-fold into 
sterile H2O. As P. aeruginosa PA14 has two CRISPR loci, both sites were amplified 
by PCR in order to detect spacer acquisition. The master mix contained 5µL of 
DreamTaq Green (2x) (Thermo Scientific), 0.1µL of 100pmol/µL forward primer, 
0.1µL of 100pmol/µL reverse primer, 3.8µL of H2O and 1µL of 10-fold diluted 
bacterial single colony per reaction. The CRISPR1 locus primers were as follows; 
forward CTAAGCCTTGTACGAAGTCTC, reverse 
CGCCGAAGGCCAGCGCGCCGGTG. CRISPR2 locus contained a forward primer 
of GCCGTCCAGAAGTCACCACCCG and a reverse primer of 
TCAGCAAGTTACGAGACCTCG. The product amplification process followed a PCR 
program of a single cycle of 10 minutes at 95°C, 35 cycles with 30 seconds at 95°C, 
30 seconds at 50°C and 45 seconds at 72°C followed by a final cycle of 7 minutes at 
72°C. Products were then run through a 2% Agarose gel, comprised of TAE (40mM 
Tris-Acetate and 1mM EDTA) solution (Fisher Scientific) and containing RedSafeTM 
Nucleic Acid Staining solution (20 000x) (iNtRon biotechnology). Spacers were 
counted by observing the amplicon size in comparison to 1kb Hyperladder (Bioline) 
and the original WT strain.  
 
2.4 Evolution experiment 
In order to investigate the evolution of CRISPR immunity to the collection of phages 
in Table 1, approximately 106 cfu/mL P. aeruginosa PA14 (WT) were infected, 
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separately, with 104 pfu/mL of phages DMS3vir, 1214, 109, 68, M4, LPB1, LMA2 and 
LUZ24 at time point 0. In addition, daily infections of 104 pfu/mL, were set up in 
parallel to test which host defence mechanism would evolve in continuous parasite 
exposure. Each experiment was performed in 6 replicates and bacteria were grown 
at 37°C in shaking conditions of 180rpm. Cultures were transferred on a daily basis, 
into fresh medium at a proportion of 1:100 for a total of 19 days. The experiment was 
conducted over this set amount of time with the hypothesis that resistance may 
develop slowly with novel phages. Single colonies were isolated at 19 days post 
infection (dpi) to establish phage resistance and to determine spacer incorporation. 
Colonies were picked at random. In addition, morphology of individual colonies were 
analysed since surface modification mediated resistance against pilus-specific phage 
is associated with a round and smooth colony morphology, whereas sensitive cells 
or CRISPR-Cas mediated resistance show spreading morphologies. In addition, 
chloroform extractions were conducted to deduce final phage concentrations in all 
replicates. 
 
2.5 Competition assays 
Competition assays were conducted to measure the fitness associated with CRISPR 
immunity relative to surface modification mutation. In order to test this, 
bacteriophage-insensitive mutants (BIMs; bacteria that have acquired a spacer that 
provides CRISPR immunity) and the surface mutants (sm1 and sm2) were 
independently grown overnight in 10mL 0.2% glucose M9 media. Overnight cultures 
were then combined at a 1:1 ratio by mixing 500µl of each BIM and sm mutant 
culture, where BIM-4 and BIM-1214 were mixed, separately, with sm1 and BIM-
LPB1 with sm2. Mixed cultures were inoculated, in replicates of 6, into microcosms 
containing 6mL of 0.2% glucose M9 media and allowed to incubate for 24h, 
whereupon cultures were transferred into fresh media. In addition, competitions 
between BIM-LPB1 and sm2 were performed in glucose concentrations of 0.02% 
and 0.002% to test the effect of lower resource abundance on the relative fitness of 
CRISPR immunity. Competitions were then tested in the presence of phage, where 
106 pfu/mL phage was added at the start of the competition to all 6 replicates of 
mixed cultures. Samples were taken every 24h, diluted and plated onto 1.5% LB 
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agar supplemented with 50µg/mL of X-gal. Plates were incubated for 48h to 
determine the relative frequencies of the competing strains at each time point. The 
blue colour of sm colonies, resulting from the LacZ insertion into the ancestral strain, 
allowed them to be distinguished from the BIM colonies (white). Colony frequencies 
were counted and used to calculate the relative fitness using the equation: 
 
𝑅𝑓 =  
(𝑓𝑠 𝑋 𝑎𝑡 𝑡 = 𝑥) ∗ (1 − (𝑓𝑠 𝑋 𝑎𝑡 𝑡 = 0))
(𝑓𝑠 𝑋 𝑎𝑡 𝑡 = 0) ∗ (1 − (𝑓𝑠 𝑋 𝑎𝑡 𝑡 = 𝑥))
 
 
Equation describing the Relative fitness (Rf) (Ross-Gillespie et al. 2007), where fs is 
the fraction of strain X, X is the fraction of CRISPR colonies to sm colonies, and t is 
the time point. When the relative fitness =1, fitness of CRISPR = fitness of sm. 
CRISPR provides a fitness benefit when the relative fitness > 1, and a cost when the 
relative fitness < 1. 
 
 
2.6 Statistical analysis 
Data were analysed using SPSS software (IBM Corp. Released 2012. IBM SPSS 
statistics for Windows, Version 21.0. Armonk, NY, USA) and Sigma-plot (SigmaPlot 
version 12.5, Systat Software, Inc., San Jose, California, USA) was used for the 
creation of graphs. 
 
As the data did not meet the assumptions of a parametric test, non-parametric tests 
were used to test for significance. To assess whether the proportion of resistant and 
sensitive mutants between single phage treatments, at 19dpi, were significantly 
different, Kruskal-Wallis tests were used. A Wilcoxon signed-rank test was then used 
to assess whether the proportions of CRISPR and sm mediated resistance differed 
between phage treatments.  
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The relative fitness results were analysed to determine whether the relative fitness of 
different BIM mutants were significantly different and whether the relative fitness of 
CRISPR mutants differed between mutants with LPS or pilus binding derived phage 
DNA. I used parametric t-tests or one-way ANOVA where model assumptions could 
be met, otherwise non-parametric equivalents were used. To test for significance, all 
analyses applied α = 0.05. 
 
 
 
Table 1: Phages used in experimental procedures 
 
 
 
 
 
 
 
 
Name Source Reference Morphology Morphotype 
species 
 
Receptor 
DMS3vir Patient at Dartmouth 
Hitchcock Medical 
Center, Vermont, USA, 
2004 
Cady & 
O’Toole (2011) 
Siphoviridae D3112 Pilus 
1214 Sewage,  
Lindberg collection,  
Texas, USA, 1964 
Lindberg & 
Latta (1974) 
Myoviridae A1 PB-1 Pilus 
109 Sewage,  
Lindberg collection,  
Texas, USA, 1964 
Lindberg & 
Latta (1974) 
Myoviridae A1 PB-1 Pilus 
68 Sewage,  
Lindberg collection,  
Texas, USA, 1964 
Lindberg & 
Latta (1974) 
Myoviridae A1 φkz Pilus 
M4 Sewage,  
Lindberg collection,  
Texas, USA, 1964 
Lindberg & 
Latta (1974) 
Myoviridae A1 Li-24 Pilus 
LPB1 Hospital sewage,  
Belgium, 2006 
Ceyssens et 
al. (2009) 
Siphoviridae D3112 LPS 
LMA2 River,  
Maastricht, Holland, 2007 
Ceyssens et 
al. (2009) 
Myoviridae PB-1 LPS 
LUZ24 Hospital sewage,  
Leiden, Holland 2004 
Ceyssens et 
al. (2009) 
Podoviridae LUZ24 LPS 
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3. Results 
 
 
3.1 Evolution experiments 
When exposing PA14 to phages described in Table 1, both with single infections at 
time point 0 and with daily infections, I found that resistance evolved in all phage 
treatments (Figure 1 and Figure 2). However, CRISPR-mediated immunity was 
limited in response to any of the phages tested. Instead, bacteria evolved almost 
exclusively surface modification immunity. Statistical analysis showed that there was 
no significant difference in CRISPR-mediated resistance between phage treatments 
with single infections (Kruskal-Wallis: X2 = 9.182, df = 7, P = 0.240, Figure 1) or daily 
infections (Kruskal-Wallis: X2 = 13.3, df = 7, P = 0.065, Figure 2). Thus, the 
previously observed high level of CRISPR immunity against DMS3vir (Westra et al. 
2015, Figure 1 Chapter 3) is not a general observation across phage infecting P. 
aeruginosa strain PA14. 
 
A Wilcoxon signed-rank test then assessed the proportion of resistance, irrespective 
of defence mechanism, to different phage treatments. Results showed that the total 
proportion of resistance (i.e. CRISPR and sm-mediated combined) did differ between 
different novel phages (Wilcoxon signed-rank test: T = 3, n = 48, N = 48, P<0.001), 
showing that, under some phage conditions, bacterial populations contain more 
sensitive individuals than others.  
 
With a limited number of CRISPR clones across all single phage treatments, phage 
extractions were conducted at 19dpi to determine whether phage had persisted or 
ceased. Phage presence was seen in treatments with phages 1214 (3 x 108 pfu/mL), 
109 (6 x 108 pfu/mL), 68 (9 x 106 pfu/mL), M4 (1 x 108 pfu/mL), LPB1 (1 x 109 
pfu/mL) and LUZ24 (4 x 109), confirming that with populations containing high levels 
of sm mutants, phage is able to persist. However, phage DMS3vir and LMA2 had 
been driven extinct at 19dpi.   
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Figure 1: Average fraction of CRISPR-Cas resistance, sm-mediated 
resistance and sensitive cells in different phage treatments at 19 dpi (days post 
infection). Initial WT infection consisted of 104 pfu/mL phage. Error bars are 
measured as 95% confidence intervals. 
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Figure 2: Average fraction of CRISPR-Cas mediated resistance, sm-mediated 
resistance and sensitive cells in different phage treatments under daily phage 
infections at 19 dpi (days post infection). Phage was added on a daily basis, where 
each infection consisted of 104 pfu/mL phage. Error bars are measured as 95% 
confidence intervals. 
 
 
3.3 Competition assays 
It was previously reported that CRISPR immunity provides a clear fitness benefit 
over sm in the presence of low titres of phage DMS3vir (Westra et al. 2015). To 
understand why CRISPR evolution was limited in response to other phages, I 
examined the fitness associated with CRISPR relative to sm in the context of 
CRISPR clones acquired from the above mentioned evolution experiments with other 
phage species. To this end, competitions between CRISPR and sm mutants were 
carried out. A total of three CRISPR mutants were selected (BIM-4, BIM-1214 and 
BIM-LPB1) to compete with sm1 (lacking a pilus) or sm2 (modified LPS site) 
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mutants. To test the constitutive fitness costs associated with sm-mediated 
resistance, competitions were performed in the absence of phage (Figure 3A). 
Inducible fitness costs associated with CRISPR-mediated resistance were tested for 
in competitions in the presence of phage (Figure 3B).  
 
In the absence of phage (Figure 3A), the relative fitness average was >1 for BIM-4 
(2.29 ± 95% CI [1.2]) and BIM-1214 (3.43 ± 95% CI [1.0]). This indicates that 
CRISPR has a higher relative fitness to sm1 mutant in the absence of phage, which 
is in agreement with a constitutive cost associated with sm (Buckling & Brockhurst 
2012, Bohannan & Lenski 2000, Westra et al. 2015). By contrast, the competition 
assay between the CRISPR mutant with a spacer obtained from a LPS binding 
phage (BIM-LPB1) and the sm2 mutant, showed a relative fitness average < 1 (0.85 
± 95% CI [0.13]) in the absence of phage (Figure 3A). The LPS modified sm mutant 
(sm2), thus provided a higher fitness benefit compared to the CRISPR mutant (BIM-
LPB1). Statistical analyses confirmed that the relative fitnesses of CRISPR mutants, 
in the absence of phage, were significantly different to sm mutants in all competition 
assays (One-sample t-test: BIM-4: t5 = 9.998, P < 0.001, BIM-1214: t5 = 16.445, P < 
0.001, BIM-LPB1: t5 = 26.376, P < 0.001).  
 
In contrast to Westra et al. (2015), there was no significant difference between the 
relative fitness of CRISPR to sm1 in the presence of phage DMS3vir (relative fitness 
average = 1 for BIM-4: 1.01 ± 95% CI [0.38], Figure 3B). Interestingly, CRISPR 
mutants carrying spacers targeting the pilus-specific phage 1214 were fitter than the 
selected surface mutant (relative fitness average > 1 for BIM-1214: 1.9404 ± 95% CI 
[0.12], Figure 3B). This demonstrates that the cost of CRISPR-mediated resistance, 
in the presence of phage, is less costly than sm-mediated resistance. Again, the 
CRISPR mutant with a spacer targeting the LPS-specific phage LPB1, had a lower 
fitness than sm2 in the presence of phage (Figure 3B), with a relative fitness average 
of < 1 (BIM-LPB1 0.756 ± 95% CI [0.14]). In this study, surface modification to the 
LPS binding site used by phage LPB1 is therefore less costly than initiating an 
adaptive immune response in the presence of the same phage. These results are 
supported by statistical analysis, where the difference in relative fitnesses of 
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CRISPR to sm were significantly different (One-sample t-test: BIM-4: t5 = 4.316, P = 
0.008, BIM-1214: t5 = 31.716, P < 0.001, BIM-LPB1: t5 = 10.282, P < 0.001). This 
explains why CRISPR immunity fails to evolve in response to the LPS binding phage 
LPB1. 
 
Given that different phage derived BIM mutants were used to measure relative 
fitnesses, the differences between BIM mutants were compared to see whether the 
relative advantage of CRISPR over sm differed between phages. An ANOVA 
showed that there was no difference in CRISPR fitness between treatments in the 
absence (one-way ANOVA: F2,15 = 3.369, P = 0.062) of phage but there was a 
difference in presence (one-way ANOVA: F2,15 = 27.597, P < 0.001) of phage. Thus 
there was limited constitutive costs in the absence of phage and inducible fitness 
costs in the precence of phage. 
 
As the competition assays between sm2 and BIM-LPB1, both in the absence and 
presence of phage, showed a CRISPR relative fitness average <1, competitions 
were also performed in media of lower glucose content (0.02% and 0.002%). This 
was to test whether the relative fitness of CRISPR depends on resource 
concentrations, i.e. whether the cost of sm is increased under further nutrient limiting 
conditions. This hypothesis is based on previously observed resource-dependent 
costs of resistance in other organisms (Boots 2011) as well as bacteria (Lopez-
Pascua & Buckling 2008). However, the relative fitness average remained <1 (Figure 
4), again in 0.2% glucose (0.954 ± 95% CI [0.04]), and also in both 0.02% glucose 
(0.911 ± 95% CI [0.022]) and 0.002% (0.772 ± 95% CI [0.05]) glucose media. This 
shows that, even in reduced resource environments, a CRISPR with a spacer 
targeting a LPS-specific phage does not confer a higher relative fitness to a LPS sm 
mutant. Relative fitness’s were confirmed to be significantly different between 
nutrient limiting conditions (One-sample t-test: 0.2% glucose: t5 = 11.1, P < 0.001, 
0.02% glucose: t5 = 19.81, P < 0.001, 0.002% glucose: t5 = 7.53, P = 0.001), where 
the relative fitness of CRISPR is seen to decrease with decreasing glucose levels. 
However, there was no significant difference in CRISPR fitness between treatments 
(one-way ANOVA: F2,15 = 1.36, P = 0.287). Thus, this shows that the relative fitness 
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of CRISPR immunity relative to a LPS sm mutant is not only consistently lower in 
different nutrient limiting environments, but also decreasing with decreasing nutrient 
availability. 
 
 
 
 
 
 
Figure 3: Relative fitness of CRISPR versus sm-mediated resistance. Competitions 
were held in the absence (A) and presence (B) of phage. The competitions were; 
DMS3vir resistant CRISPR mutant (BIM-4) with sm1 mutant (lacking a pilus), phage 
1214 resistant CRISPR mutant (BIM-1214) with sm1 mutant and LPB1 resistant 
CRISPR mutant (BIM-LPB1) with sm2 mutant (with modified LPS binding sites). 
Final phage titrations in competitions experiments in the presence of phage were; 
1.6 x 1010 pfu/mL (BIM4), 6 x 1010 pfu/mL (BIM-1214) and 1 x 1010 pfu/mL (BIM-
LPB1). Error bars show 95% confidence intervals. 
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Figure 4: Competition assay of BIM-LPB1 in different nutrient limiting conditions. 
The graph shows the relative fitness of a LPS phage derived CRISPR mutant when 
competed with a LPS mutant. Relative fitness’s of BIM-LPB1 were all <1. Error bars 
are shown as 95% confidence intervals.  
 
 
4. Discussion 
 
Here I show how novel phages do not necessarily induce CRISPR-Cas mediated 
resistance in their sensitive hosts, even when CRISPR generally provides higher 
fitness than the alternative immune strategy of sm. Single phages were used to 
infect the pathogenic bacteria Pseudomonas aeruginosa to test which defence 
mechanism, CRISPR-Cas or sm, would be elicited upon infection. In both cases of 
single (Figure 1) and continuous (Figure 2) infections, resistance was shown to be 
mainly expressed through cell surface modification.  
 
  33  
  
It was curious that at 19dpi (days post infection) of phage DMS3vir, little CRISPR 
mediated resistance was observed as a previous study showed that DMS3vir 
infections of P. aeruginosa WT PA14 conveyed an almost 100% CRISPR mediated 
resistance at 3dpi (Westra et al. 2015, Figure 1 Chapter 3). In addition, phage 
removal from the environment had led to renewed DMS3vir sensitivity. If the 
presence of a phage derived spacer sequence in the host genome does not infer a 
fitness cost in the absence of phage, then CRISPR mutants should have been able 
to persist in the environment. As it is, they did not. Even though competition assays, 
with pilus mutants, demonstrated that CRISPR mutants inferred a greater relative 
fitness benefit than sm, in the absence of phage, the numbers of CRISPR mutants in 
these populations were low. It may be that, phage had already overcome host 
resistance. If a bacterial population evolved to contain only one or two CRISPR 
clones, counter-resistance by phage could easily be achieved by point mutations in 
the phage genome (Deveau et al. 2008). This would allow the phage to escape the 
response of the adaptive immune system and instead remove the limited number of 
CRISPR clones from the population. Another explanation is that, as phage were in 
some cases cleared from the environment the spacer sequences that recognised 
these phages were lost over time due to limited selection for resistance. This 
suggests that there is still a cost of CRISPR-Cas resistance in the absence of 
phages.    
 
Phage managed to persist in six out of eight single phage infections, where complete 
phage extinction was observed for DMS3vir and LMA2. Phage extinctions are not 
uncommon and have been documented in experimental evolution experiments with 
E.coli and virulent T-phages (Lenski & Levin 1985, Bohannan & Lenski 2000). Phage 
extinction with concern to phage DMS3vir was not surprising as a new study has 
shown its early extinction is due to the generation of high levels of CRISPR diversity 
(Chapter 5). The rate of evolution between bacteria and phage can be seen as 
different as spacer acquisition by the CRISPR-Cas system is fast and point 
mutations in specific proto-spacer sequences in the phage are slow. This explains 
why bacterial populations can rapidly drive phage to extinction. On the other hand, 
as resistance was seen to be 100% sm mediated and no CRISPR-Cas mediated 
resistance was detected in the case of a LMA2 infection, it was surprising to see 
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phage clearance. As extinction has occurred, phage disappearance can be 
explained by the gradual dilution over time, as a result of experimental transfers.  
 
It could also be explained by the degradation of the phages over time, which has 
been observed to occur in a different bacteriophage-host environment (Cairns et al. 
2009). Another explanation, arising from deeper DNA sequence analysis, is that the 
CRISPR locus of P. aeruginosa carried a perfect match to phage LMA2. This means 
that the recognition, and possible resistance, was already in place in the bacterial 
genome prior to experiments carried out in this study. Therefore, as new spacers 
were not generated, and the WT strain is sensitive to this phage, it is likely that 
LMA2 carries a CRISPR inhibitor. It has recently been documented that some phage 
may have anti-CRISPR genes (or CRISPR inhibitors) (Bondy-Denomy et al. 2013), 
where these genes allow the phage to evade the CRISPR-Cas system. Thus, the 
inability of the bacteria’s CRISPR-Cas system to incorporate new phage LMA2 
spacers is why resistance was conveyed via surface modification.   
 
Curiously, a CRISPR clone demonstrated a lower relative fitness to its competitor; 
the LPS surface mutant (sm2) in both the presence and absence of phage. This 
shows that the alterations to LPS sites, in these experiments, did not induce the 
same level of costs as seen with a pilus sm. The functions of the altered bacterial 
LPS sites are not presently known, which means that the costs associated with their 
alterations could not be fully understood. Also, this study was limited to testing the 
competition of only one CRISPR clone containing a LPS binding phage derived 
spacer, making it difficult to conclude that the modification of LPS binding sites are 
generally less costly than an adaptive immune response. However, the disadvantage 
of having CRISPR resistance could not have been due to differences in resource 
levels (Figure 4). This suggests that there are still other factors that are important in 
driving the evolution of a CRISPR-Cas adaptive immune response.  
 
It is unclear as to why a CRISPR-Cas-mediated resistance was not prevalent across 
different phage species. With resistance through spacer incorporation being high in 
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DMS3vir infections of P. aeruginosa (Westra et al. 2015), it was surprising that 
different phage species did not reflect this observation. The concept of priming may 
be key to understanding these results. Priming relies on partial spacer 
complementarity to phage genomic sequences in order for increased spacer 
incorporation to occur (Datsenko et al. 2012). As priming is important with P. 
aeruginosa to phage DMS3 (Cady et al. 2012), the lack of complementarity of 
spacers to the novel phages used in this study may explain why limited spacer 
incorporation, and therefore lack of priming possibilities, was observed across phage 
infections. 
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Chapter 2 
 
The effects of multiple bacteriophages on the evolution of resistance in 
the bacteria Pseudomonas aeruginosa.  
 
Abstract 
 
Two key mechanisms employed by prokaryotes for parasite defence are surface 
modification (sm) and the CRISPR-Cas (Clustered Regularly Interspaced Short 
Palindromic Repeats – CRISPR associated) system. CRISPR-Cas provides highly 
specific immunity, whereas sm immunity can either be very specific, with a subtle 
mutation to a receptor providing immunity to a single phage, or broad range where a 
drastic mutation (such as receptor loss) can provide immunity to a group of phages. 
As described in Chapter 1, Pseudomonas aeruginosa evolves CRISPR-Cas 
immunity primarily in response to phage DMS3vir, while other phage species in our 
collection mainly trigger sm-mediated immunity. Although it is important to study the 
effects of single phage species infections on the evolution of defence mechanisms, 
single infections may be rare in a natural setting. Here, I investigate how phage 
diversity might affect the evolution of bacterial defence mechanisms. Firstly, I mixed 
pilus-specific phages, including DMS3vir, where I found that mixed infections 
consistently trigger the evolution of sm immunity. Secondly, the exposure of bacteria 
to LPS-specific phage mixes, that all trigger highly specific sm (i.e. no initial cross 
resistance), resulted in broad range sm resistance against all phages. Collectively, 
these data show that phage diversity in the environment drives sm immunity over 
CRISPR-Cas.  
 
1. Introduction 
 
Hosts are under constant threat by parasite infection where an infection can drive the 
evolution of different resistance mechanisms (Brockhurst et al. 2005, Frank 1993). 
As such, the force of infection or different ecological factors will determine the benefit 
of one defence mechanisms over another. Thus, the optimum defence mechanism 
will depend on the type of infection(s), where parasite(s) cause either a general or 
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specific resistance response. Parasite diversity may also be instrumental in the 
evolution of different resistance mechanisms, however, little is known on how 
parasite diversity will affect the choice in elicited immune response.  
 
Host resistance often carries a fitness cost (Koskella et al. 2011, Perron et al. 2007, 
Rigby et al. 2002). For example, bacterial cell surface modifications (sm) may be 
costly if unable to provide effective resistance to highly specific parasites (Koskella et 
al. 2011), novel parasites or if multiple modifications to surface structures are 
required (Bohannan et al. 1999, Levin & Bull 2004). If multiple structural alterations 
occur, the number of necessary specific resistances may result in an accumulative 
fitness cost as each specific resistance carries a cost (Koskella et al. 2011). 
Additionally, the alterations made in generating multiple structural modifications may 
be costly to the host continued in the absence of parasites. On the other hand, sm-
mediated resistance may provide cross-resistance against phages targeting similar 
receptors, reducing the cost of acquiring the modification (Hall et al. 2012), and 
proving beneficial in parasite diverse environments where this defence provides 
general host immunity.  
 
Adaptive immunity, such as the parasite-specific resistance provided by the 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats – 
CRISPR associated) system, is another form of host defence and is cost free in the 
absence of parasites (Hamilton et al. 2008, Westra et al. 2015). Through the 
incorporation of unique parasite sequences, known as spacers, the adaptive function 
of the CRISPR-Cas system allows an organism to adapt to specific and multiple 
different parasites as resistance is continuously renewed (Barrangou & Marraffini 
2014). Even though an adaptive immune system imposes a cost when activated 
(Vale et al. 2015, Westra et al. 2015), the host is saved from continued fitness costs 
inflicted from a parasitic attack upon clearance of the very same infection. 
 
It has been proposed that, in the face of parasite diversity, the probability of rapid 
spacer acquisition to several bacteriophages (phages) at once by the CRISPR-Cas 
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system is rare (Weinberger et al. 2012). Where studies have shown eventual phage 
extinction in bacterial evolution experiments containing single phage species 
infections, the presence of a second phage species showed extended host-phage 
co-evolution (Paez-Espino et al. 2015). Thus, with the addition of another phage 
species, the host’s ability to eliminate phage presence decreased with increasing 
phage diversity. The population-genetic mathematical model of virus-CRISPR 
dynamics described by Weinberger et al. (2012) speculates that if a CRISPR clone 
has simultaneously acquired a spacer against two phages, it will sweep through the 
bacterial population in the presence of both phages. Hence, this CRISPR clone is 
able to go to fixation if it acquires immunity to both viral-subpopulations in a 
population. This suggests that spacer acquisition to multiple phage species is 
possible, however, it is unclear which phage conditions (i.e. phage species targeting 
different host receptors) are likely to select for CRISPR-Cas immunity. 
 
In the current study, I exposed the opportunistic pathogen Pseudomonas aeruginosa 
strain PA14 to different multiple bacteriophages to determine which host defence 
mechanism (CRISPR-Cas system or sm) evolves. By infecting P. aeruginosa with a 
gradual increase of pilus-binding bacteriophages, I could test whether the previously 
observed high levels of CRISPR-Cas resistance to DMS3vir (Westra et al. 2015) is 
maintained in combination with other pilus-specific phages. In this context, sm 
provides cross-resistance and was hypothesized to be favoured over CRISPR-Cas. 
Next, P. aeruginosa was exposed to different LPS-specific phage mixtures. LPS 
specific phages were used as bacterial surface modifications associated with 
resistance to these phages are specific and thus offer no cross-resistance. Hence, it 
was hypothesized that mixed infections would favour CRISPR-Cas mediated 
resistance.   
 
 
2. Materials and Methods 
 
The same bacterial strains and phages as described in Chapter 1 were used 
throughout the following experiments. Bacterial growth media also remained the 
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same. Spacer acquisition was monitored and streak assays were performed to 
measure resistance, both of which were carried out as in Chapter 1. 
 
2.1 Multiple phage experiments 
Evolution experiments with combinations of multiple phages were set up to test 
which immune response would be elicited in multiple parasite conditions. Mixed 
phage populations were created by combining 1 x 106 pfu/mL solutions of each 
appropriate phage. A full description of all phages used can be found in Table 1 of 
Chapter 1. The pilus binding phages used were DMS3vir, 1214, 109, and M4. As 
resistance to DMS3vir at 3dpi (days post infection) is almost 100% CRISPR-Cas 
mediated (Westra et al. 2015), all pilus binding mixtures contained DMS3vir. This 
was to test whether DMS3vir in combination would elicit the same resistance 
response as with single phage species infection. Thus, the treatments consisted of 
two phages (DMS3vir and 1214), three phages (DMS3vir, 1214, and 109) and four 
phages (DMS3vir, 1214, 109, and M4). This is not a comprehensive list of 
combinations, however, these combinations will provide an insight to whether the 
gradual increase in phage diversity affects the resistance evolution between P. 
aeruginosa and phage DMS3. 
 
Mixtures of LPS binding phages were also used to test whether the pressure of 
modifying different LPS sites would affect which defence mechanism would be 
elicited upon infection. The combinations composed of two (LMA2 and LPB1, LMA2 
and LUZ24, LPB1 and LUZ24) and all three phages (LMA2, LPB1 and LUZ24).  
 
Multiple phage experiments were performed in 6 replicates of 6mL 0.2% glucose M9 
media, which were inoculated from an overnight culture with ~ 106 WT cells. 
Approximately 104 pfu/mL of combined phage particles were then added to their 
respective treatment. After three days of daily transfers, treatments were diluted and 
plated onto 1.5% LB agar. Single colonies were randomly selected for PCR 
amplification and subsequent spacer acquisition determination. Colonies were also 
tested for resistance to all phages involved in each treatment. Furthermore, for 
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experiments containing two LPS binding phages, cross-resistance was tested for by 
performing a streak assay across a LPS binding phage not used in the given mixed 
treatment. 
 
2.2 Statistical analysis 
A description of the statistical packages used can be found in Chapter 1.  
Kruskal-Wallis tests were used to determine whether the difference between the 
fractions of CRISPR versus sm mutants, in the multiple phage experiments, were 
likely to have occurred due to a particular phage treatment. Pilus and LPS 
experiments were grouped separately where differences in the fraction of CRISPR 
mediated resistance were tested across treatments. To test for significance, all 
analyses applied α = 0.05. 
 
 
3. Results 
 
3.1 Multiple phage experiments 
It is unclear whether CRISPR-Cas mediated resistance is advantageous in the face 
of multiple parasite infections. P. aeruginosa evolves almost exclusively CRISPR-
Cas mediated immunity against DMS3vir at 3dpi (Westra et al. 2015), but evolves 
sm-mediated resistance against other pilus specific phage species (Chapter 1). The 
same qualitative results as in Westra et al. (2015) at 3dpi of DMS3vir are shown in 
figure 1 of Chapter 3. This surface modification results in cross-resistance between 
the different phages (Figure 1). So, in all multiple pilus binding experiments results 
showed, mixes of; two (DMS3vir and 1214), three (DMS3vir, 1214 and 109), or four 
phages (DMS3vir, 1214, 109 and 68) almost solely evolved sm-mediated resistance, 
with low levels of CRISPR-mediated resistance occurring in treatments with two or 
four phages (Figure 1).  
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P. aeruginosa was exposed to mixes of LPS-specific phages. Again, sm-mediated 
resistance was the most prevalent means of resistance when different LPS-specific 
phages were combined (Figure 2). Each of these phages trigger specific surface 
modification based resistance on their own. Crucially, bacterial clones with sm 
resistance against one LPS-specific phage remained sensitive to other LPS-specific 
phages (Figure 3). Hence, no cross-resistance was observed. 
Statistical analysis showed no significant difference between mixed phage 
treatments on the level of CRISPR mediated resistance immunity for the multiple 
pilus binding phage experiments (Kruskal-Wallis: X2 = 2.267, df = 2, P = 3.22) or 
multiple LPS binding phage experiments (Kruskal-Wallis: X2 = 4.016, df = 3, P = 
0.260). This shows that the differences in phage species used in multiple phage 
treatments did not cause differences in expressed resistance. These data show that 
the presence of multiple phages consistently triggers the evolution of sm based 
immunity. 
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Figure 1: Average fraction of CRISPR-Cas mediated resistance versus sm-mediated 
resistance in treatments containing multiple pilus binding phages at 3 dpi (days post 
infection). The treatments are as follows; two phages (DMS3vir and 1214), three 
phages (DMS3vir, 1214, and 109) and four phages (DMS3vir, 1214, 109, and 68). 
Error bars indicate 95% confidence intervals. 
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Figure 2: Average fraction of CRISPR-Cas mediated resistance versus sm-mediated 
resistance in multiple LPS binding phage treatments at 3 dpi. WT was infected with 
treatments of two or three phages. The phage treatments are represented on the x-
axis. Error bars indicate 95% confidence intervals. 
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Figure 3: Cross-resistance in multiple LPS binding phage experiments. The graph 
shows the average fraction of phage resistance across multiple LPS phage 
treatments at 3dpi. Cross-resistance was tested for by exposing treatments to a 
different LPS phage. Each bar represents resistance to phage LPB1, LMA2 or 
LUZ24. Error bars indicate 95% confidence intervals. 
 
 
 
 
4. Discussion 
 
I investigated the effect of multiple phage species on elicited immune defence in the 
bacterium Pseudomonas aeruginosa. Specifically, I tested if pilus-binding phage 
DMS3vir would still evoke CRISPR-Cas mediated immunity when mixed with other 
pilus-specific phages. I also investigated whether phages that do not inflict sm cross-
resistance in their hosts during single infections, would trigger CRISPR-Cas 
immunity when mixed due to the otherwise multiple surface alterations needed to 
provide general resistance. It has been suggested, that an adaptive immune system 
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is beneficial in the face of phage diversity (Barrangou & Marraffini 2015), however, 
my results contradict this hypothesis. Neither multiple pilus nor LPS binding phage 
combinations, produced resistance by spacer incorporation through the CRISPR-
Cas system. Instead, these results overwhelmingly show cell surface modification as 
a means of resistance. 
 
It is surprising that surface modification was the most prevalent mode of resistance 
as, for example, the consequences of losing pili are reduced biofilm formation 
(O’Toole & Kolter 1998) and limited motility (Burrows 2012), which are vital 
mechanisms in a movement dependent environment. Reversing such modifications 
is possible but rare (Taylor et al. 2015). Thus, the cost of losing this structure can 
only be accounted for if another factor, such as cell death, imposes an even higher 
cost, or if resistance to multiple phages can be gained when all phages bind to the 
same receptor. This explains the high level of sm mediated resistance seen in the 
multiple pilus phage experiments.  
 
On the other hand, competition between phages may explain the lack of adaptive 
evolution in multiple pilus phage treatments containing DMS3. There is evidence that 
different phage species may compete for the same receptor site (Lenski 1988). 
Thus, co-infection of multiple pilus binding phages may have resulted in phage-
phage competition, reducing the chances of phage DMS3 triggering resistance 
evolution by adaptive immunity. Phage-phage competition may also affect lysis time 
as cell lysis will be determined by the phage with the fastest lysis time (Refardt 
2011). Therefore, if phage DMS3 has a slow lysis time, reduced numbers of DMS3 
phage may explain why limited adaptive evolution has occurred.    
 
It was surprising to see modifications to several LPS sites in the multiple LPS phage 
evolution experiment as alterations to many different surface structures have been 
predicted to be costly (Koskella et al. 2011). A future direction of this study would be 
to combine pilus binding and LPS binding phages. Even though phage species are 
genetically dissimilar, the sm required to confer cross-resistance to all phages may 
be too costly if phages bind to different host receptors. In a study by Avrani et al. 
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(2011), it was shown that host mutations that offered resistance to some phages, 
caused rapid infection by others. If parasites challenge different receptors on the cell 
surface, it is likely that the cost of modifying several of these sites will be too great, 
thus prompting another form of defence, such as adaptive immunity, to cope with the 
threat of infection. 
 
The fact that adaptive immunity failed to evolve against most individual phages 
(Chapter 1) may explain why it is not observed in multiple phage treatments. A 
reason for this may be that P. aeruginosa needs to be primed before the adaptive 
process of the CRISPR-Cas system can actively incorporate phage derived spacer 
sequences. However, in order for P. aeruginosa to be primed, a spacer needs to 
already offer a partial match to a phage sequence. This mismatch will trigger the 
generation of new spacers as it offers some recognition to a phage sequence 
(Richter et al. 2014, Swarts et al. 2012). Host immunity can then be actively renewed 
by the positive-feedback process of priming as phages simultaneously co-evolve to 
mutate mismatches of the targeted spacer sequences in its own proto-spacer 
(Fineran et al. 2014). Several studies have shown that the first spacer incorporation 
event highly influences the positive-feedback process of the CRISPR-Cas adaptive 
immune system (Datsenko et al. 2012, Swarts et al. 2012). Thus, the lack of a 
primed system in this chapter and Chapter 1 may explain why adaptive immunity has 
been limited. Therefore, establishing a primed system between P. aeruginosa PA14 
WT strain and a novel phage may enlighten the results observed in this chapter. My 
next chapter will therefore examine the importance of the priming phenomenon in the 
evolution of CRISPR-Cas mediated immunity in this experimental system. 
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Chapter 3 
 
The importance of priming in CRISPR-Cas mediated resistance 
 
Abstract 
 
Bacteria can evolve immunity by surface modification or through the CRISPR-Cas 
(Clustered regularly interspaced short palindromic repeats - CRISPR-associated) 
system. However it has been noted that, even though CRISPR-Cas immunity is often 
associated with higher fitness levels, it frequently fails to evolve against single 
(Chapter 1) and multiple (Chapter 2) phages. Here I investigate the importance of a 
process known as “priming” for the evolution of CRISPR immunity. Priming occurs 
when a pre-existing spacer has partial complementarity to the infecting phage. It is 
well-established that priming increases the rate of incorporation of new spacers in 
many different environmental systems. I found that removing a spacer from the 
CRISPR locus that is predicted to mediate priming against DMS3vir reduces the rate 
of CRISPR-Cas evolution. Additionally, I found that bacterial clones carrying a 
spacer against phage 68 evolved increased levels of CRISPR-Cas immunity in 
comparison to the ancestral bacterial host. However, the levels of evolved immunity 
against phage 68 by primed bacteria were much lower than those observed for 
DMS3vir, suggesting that other phage life history traits may be important.  
 
 
1. Introduction 
 
Clustered regularly interspaced short palindromic repeats (CRISPRs), along with 
CRISPR-associated (Cas) proteins provide adaptive immunity to foreign genetic 
material in prokaryotes (Sorek et al. 2008). Bacteria will incorporate bacteriophage 
(phage) nucleic acid sequences, termed spacers, into its CRISPR loci when this 
novel foreign invader is encountered (Yosef et al. 2012). Host immunity is gained as 
spacer sequences are highly specific and provide homologous sequence recognition 
to the corresponding phage proto-spacer sequence. However, immunity can be lost 
if phage acquire point mutations to either the target proto-spacer sequence, the PAM 
  48  
  
(proto-spacer adjacent motif) or the seed region of the phage proto-spacer 
(Datsenko 2012, Semenova et al. 2011, Sun et al. 2013). These nucleotide 
mismatches allow the phage to bypass the recognition and prospective clearance by 
the host CRISPR-Cas system, resulting in phage sensitivity (Barrangou et al. 2007). 
Although these mismatches allow phage to overcome host immunity, they also 
trigger a greatly increased rate of spacer acquisition, known as “primed” spacer 
acquisition. The positive-feedback process of priming leads to the incorporation of 
new spacers to restore immunity, and presumably relies on partial recognition to 
escape viruses (Fineran et al. 2014). Thus, by acquiring multiple spacers for the 
same invader, the host is strengthening its recognition to it and tightening the 
bacteria-phage interaction (Swarts et al. 2012). 
 
The molecular memory of the CRISPR locus provides an overview of host-parasite 
evolutionary past. Studies have shown how vital matching or mismatching in a pre-
existing spacer to a previously encountered parasite is for efficient priming to occur. 
In fact, priming is considered a prerequisite for the evolution of CRISPR-Cas 
immunity and has been shown in Escherichia coli, (Datsenko et al. 2012), 
Pectobacterium atrosepticum (Richter et al. 2014) and Haloarcula hispanica (Li et al. 
2013). Another study showed that priming can occur when a novel parasite 
resembles a previously encountered parasite. Therefore, host resistance can be 
rapidly generated to a previously unknown parasite, simply by having mismatches in 
spacer sequences to a known one (Fineran et al. 2014). Thus, different mismatches 
can trigger different strengths of priming.  
 
Here I investigate whether the prerequisite for priming explains why Pseudomonas 
aeruginosa strain PA14 evolves CRISPR-Cas immunity against some, but not all, 
phage species (Chapter 1). I investigate the importance of priming using two 
complementary approaches. First, I generate bacteriophage insensitive mutants 
(BIMs) with CRISPR-Cas immunity against phage 68, followed by the generation of 
phages that bypass this CRISPR-Cas immunity. Next, I test the frequency of spacer 
acquisition in response to these escape phages using the ancestral strain PA14 and 
BIMs as hosts. Additionally, I examine the effect of removing a spacer that is 
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predicted to mediate priming of strain PA14 against DMS3vir, in order to test the 
evolution of CRISPR-Cas immunity against DMS3vir in an unprimed system.  
 
 
2. Materials and Methods 
 
2.1 Bacterial strains, phages, and media 
 
Bacteria and bacterial growth media 
Pseudomonas aeruginosa wild type (WT) PA14, P. aeruginosa CRISPR-Cas knock-
out strain csy3::LacZ (LacZ), and P. aeruginosa WT PA14 derived knock-out strains 
CRISPR2 Δ spacer 1-2 (SMC4707) and CRISPR2 Δ spacer 2-21 (SMC4577) were 
used throughout experiments and were all supplied by the O’Toole lab (Cady & 
O’Toole 2011) at the Geisel School of Medicine (Hanover, New Hampshire, USA). 
The bacterial growth media, described in Chapter 1, was used throughout the 
following experiments. 
 
Phage 
Phage 68 is a part of the Lindberg phage collection, supplied by the Davidson lab 
(University of Toronto, Ontario, Canada), and was chosen to test the efficiency of 
priming to a novel phage. A stock solution of phage 68 was generated by combining 
10µL of 106 pfu (plaque forming units) /mL and 300µL of overnight grown LacZ cells 
to 9mL of 0.5% LB agar and poured onto 1.5% LB agar where overnight growth in 
37°C allowed near confluent lysis to be reached. Plates were then flooded and left 
for 2 hours with 10mL M9 salts to retrieve phage and bacteria from the LB agar. To 
clear bacterial cells from phage lysate, the liquid was chloroformed and centrifuged 
at 35000 rpm (rotations per minute) for 10 minutes. Whereupon, final phage stock 
titrations, in pfu/mL, were determined by diluting and pipetting 5µL of 10-fold 
supernatant dilutions onto LacZ 1.5% LB agar bacterial lawns. The stock was stored 
at 4°C. 
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Partial matches of the phage DMS3vir to P. aeruginosa WT PA14 genome exist and 
were thus used in the CRISPR knock-out experiments, described below, as a model 
for a primed system. DMS3vir was supplied by the O’Toole lab (Cady & O’Toole 
2011) (Geisel School of Medicine, Hanover, New Hampshire, USA). 
 
2.2 Streak assays and phage titration 
Streak assays and phage titrations were performed as described in Chapter 1. 
 
2.3 Spacer acquisition 
Acquisition of spacers into both, CRISPR1 and CRISPR2, CRISPR loci were 
detected through colony PCR. The primers for CRISPR1 locus were: forward 
CTAAGCCTTGTACGAAGTCTC, reverse CACCGGCGCGCTGGCCTTCGGCG. 
CRISPR2 locus had a forward primer of GCCGTCCAGAAGTCACCACCCG and a 
reverse primer of CGAGGTCTCGTAACTTGCTGA. Separate primers had to be 
designed for the CRISPR2 Δ experiments. To detect spacer acquisition for CRISPR2 
Δ spacer 1-2 a forward primer of AGCCACTGTGTCGGCCAAAACC was used. In 
treatments using the strain CRISPR2 Δ spacer 2-21, a forward primer of 
TGTGTGAGGAGCGTGAGCTTCC was designed. The reverse primer for CRISPR2 
remained the same, CGAGGTCTCGTAACTTGCTGA, in both cases. 
 
PCR reactions were prepared in the same manner as in Chapter 1, followed by the 
identical PCR program for product amplification. All materials and procedure for gel 
electrophoresis can also be found in Chapter 1. 
 
2.5 CRISPR knockout experiment 
To test the importance of pre-existing spacer sequences in the process of priming, 
CRISPR knock-out strains were challenged with phage DMS3vir. Approximately 106 
cfu/mL bacterial cells from overnight grown cultures of CRISPR knock-out strains; 
CRISPR2 Δ spacer 1-2 and CRISPR2 Δ spacer 2-21, along with WT, were 
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inoculated into microcosms containing 6mL of 0.2% glucose M9 media. Each 
treatment contained 6 replicate populations, all infected with 104 pfu/mL of DMS3vir. 
A 1:100 transfer into fresh media was performed at daily intervals until 3 days post 
infection (dpi) was reached. Cultures were diluted to 10-5 and plated onto 1.5% LB 
agar plates, where single colonies were isolated and inoculated into fresh 0.2% 
glucose media. Streak assays tested colony resistance  against DMS3vir. Single 
colony PCRs determined whether spacers had been incorporated. Phage extractions 
were also performed to establish presence or absence of phage.  
 
2.6 Bacteriophage insensitive mutant (BIM) selection and CRISPR escape phage 
(CEP) generation 
In order to generate a BIM, P. aeruginosa WT was infected with 104 pfu/mL of phage 
68 and inoculated into 0.2% glucose M9 media and allowed to incubate in 
temperatures of 20°C, 28°C and 37°C. Cultures were transferred daily (1:100) into 
fresh medium for a total of three days. Two BIMs containing one additional phage 
derived spacer were obtained as a result of this experiment.  
 
Next, escape phages to both BIMs were generated. A 1:1 mix of BIM and LacZ cells 
were inoculated into LB media containing 106 pfu/mL of phage 68. The culture was 
allowed to grow overnight. Next, a chloroform extraction to remove bacterial cells 
was performed. Remaining phage were serially diluted and spotted onto bacterial 
lawns comprised of BIMs to confirm the presence of escape phage. Escape phage 
was only generated for one of these BIMs. As this BIM contained one spacer and 
was obtained through evolution with phage 68, it was given the name BIM68-1. 
Plaque assays where then prepared to isolate a single CRISPR escape phage 
(CEP) plaque (CEP-68-1). To isolate a single colony, 10µL of 104 pfu/mL of escape 
phage stock mixture was added to 300µL BIM68-1 culture and 9mL 0.5% LB agar 
and poured onto 1.5% LB agar and allowed to incubate at 37°C overnight. This 
single CRISPR escape phage plaque (CEP-68-1) was then amplified to be used in 
evolution experiments. 
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BIM68-1 was infected with 104pfu/mL CEP-68-1, in 0.2% glucose M9 media, and 
transferred daily into fresh media for three days. Nineteen BIMs containing a second 
additional spacer were obtained from this experiment. Thus, these BIMs contained a 
total of two spacers of genetically derived material from phage 68. This time a 1:1 
mix of all nineteen BIMs and LacZ were inoculated with CEP-68-1.  Again, escape 
phage was only generated for one BIM clone, resulting in the name BIM68-2. A 
single CRISPR escape phage plaque (CEP-68-2) was isolated by plaque assay, this 
time on bacterial lawns containing BIM68-2, and amplified into a stock solution. 
A summary of the BIMs and CEPs obtained can be found in Table 1 below. 
 
 
 
Table 1: BIMs and escape phages used in experimental procedures 
 
Bacteriophage 
insensitive mutant 
(BIM) 
Number of 
spacers 
CRISPR Escape 
phage 
Resistant to 
BIM68 – 1 1 
 
CEP-68-1 
 
Phage 68 and 
DMS3vir 
BIM68 – 2 2 
 
CEP-68-2 
 
Phage 68 and 
DMS3vir 
 
 
 
2.7 Priming experiments 
P. aeruginosa clones, exhibiting different levels of primed recognition to phage 68 
(BIM68-1 and BIM68-2), were evolved separately with CRISPR escape phage 68 
(CEP-68-1 and CEP-68-2). In replicates of 6, ~106 cfu/mL of overnight grown WT, 
BIM68-1 and BIM68-2 were inoculated into 0.2% glucose media and infected with 
phage (104 pfu/mL). Primed strains, along with WT, were compared by infecting cells 
with variants of phage 68 as follows; WT with phage 68, BIM68-1 with escape phage 
CEP-68-1 and BIM68-2 with escape phage CEP-68-2. Experiments were conducted 
over a three day period, where transfers of 1:100 of overnight treatments into fresh 
media were done at daily intervals. Upon 3dpi, replicates were diluted and plated 
onto 1.5% LB agar and incubated overnight to allow single colony formations. 
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Bacterial colonies were isolated, picked and suspended in 0.2% glucose M9 media 
overnight. Viral titrations along with phage resistance and preferred resistance 
mechanism were determined at the conclusion of the experiment. 
 
2.8 Statistical analysis 
Statistical software used was the same as in Chapter 1.  
A Kruskal-Wallis test was used to assess whether there was a significant difference 
in CRISPR-mediated defence between both CRISPR knockout strains (CRISPR2 Δ 
spacer 1-2 and CRISPR2 Δ spacer 2-21) and WT, and between BIMs (BIM68-1 and 
BIM68-2) and WT. The frequency of CRISPR-Cas across replicates was also tested 
across bacterial strains with a Fisher’s exact test. To test for significance, all 
analyses applied α = 0.05 
 
 
3. Results 
 
3.1 CRISPR knockout experiment 
As spacers on the CRISPR locus reflect prior phage encounters, the removal of 
these should limit the fluidity in which additional spacers are added, thus slow the 
priming process. It has been predicted that spacer 1 on the CRISPR2 locus 
mediates priming against DMS3vir (Cady et al. 2012) due to the partial matches with 
the phage proto-spacer (Figure 3). As such, the CRISPR knockout strain containing 
the removed leader-end first two spacers (CRISPR2 Δ spacer 1-2) is believed to 
have a stronger effect on priming in comparison to the other knockout strain 
(CRISPR2 Δ spacer 2-21).   
 
Interestingly, CRISPR2 Δ spacer 1-2 showed 100% sm-mediated immunity in the 
presence of DMS3vir (Figure 1). This demonstrates that, spacers 1-2 are very 
important in new CRISPR resistance acquisition events and that the mismatches 
observed between the CRISPR2 locus to DMS3vir play a role in priming. By 
contrast, CRISPR2 Δ spacer 2-21 exhibited ~80% sm-mediated immunity, with some 
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CRISPR mediated resistance and sensitivity in the population (Figure 1). However, 
the number of spacer acquisition events in CRISPR2 Δ spacer 2-21 experiments did 
not exhibit the same high numbers observed in experiments using WT (Figure 1). As 
a result, there was a significant difference in CRISPR-mediated resistance across 
strains (Kruskal-Wallis: X2 = 14.14, P = 0.001). This highlights the importance of 
spacer 1, because even though the majority of the locus was removed, the presence 
of this spacer resulted in renewed spacer acquisition. 
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Figure 1: Average fraction of resistance (CRISPR or sm-mediated) or sensitivity in 
evolution experiments with WT or CRISPR knock-out strains in the presence of 
phage DMS3vir at 3dpi (days post infection). WT bacteria are primed to phage 
DMS3vir, whereas knock-out strains CRISPR 2 Δ 2-21 and CRISPR 2 Δ 1-2 are no 
longer primed to DMS3vir. Final phage DMS3vir titrations were as follows; 6 x 106 
pfu/mL (WT), 8 x 1010 pfu/mL (CRISPR 2Δ 2-21) and 4 x 109 pfu/mL (CRISPR 2Δ 1-
2). Error bars are measured in 95% confidence intervals. 
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3.2 Priming experiments 
Based on previous studies on E. coli showing that point mutations in the phage PAM 
(proto-spacer adjacent motif) stimulate renewed spacer acquisition in the host 
(Datsenko et al. 2012, Swarts et al. 2012), it was predicted that similar observations 
would occur in P. aeruginosa. To determine whether primed strains of P. aeruginosa 
to the novel phage 68 results in increased levels of spacer acquisition, BIMs (BIM68-
1 and BIM68-2) were evolved in the presence of escape phage 68 (CEP-68-1 and 
CEP-68-2). 
 
The majority of mediated resistance in both bacterial populations (BIM68-1 and 
BIM68-2) occurred by sm when infected with phage 68 escape phages (Figure 2). 
Spacer acquisition by BIM68-1 and BIM68-2 was limited, and there was no 
significant difference between bacterial strains on observed CRISPR-mediated 
resistance (Kruskal-Wallis: X2 = 5.57, df = 2, P =0.062). Resistance in a non-primed 
system (WT infected with phage 68, Figure 2) occurred by sm, showing that the 
acquisition of spacers by means of CRISPR-Cas is a rare occurrence in this 
particular phage-host interaction. 
 
A Fisher’s exact test was used to assess whether number of replicates producing 
CRISPR-Cas resistance was significant between bacterial strains. As a result, there 
was a significant difference (one-tailed Fisher’s exact test, P < 0.001). This shows 
that, while the difference in the fraction of spacer acquisition was insignificant, the 
detection of CRISPR-Cas resistance is greater in strains already containing 
recognition to phage 68.  
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Figure 2: P. aeruginosa PA14 (WT) and primed strains; BIM68-1 and BIM68-
2 at 3dpi of phage 68. Phage 68 infections differed and were as follows; WT with 
ancestral phage 68, BIM68-1 with escape phage 68 (CEP-68-1) and BIM68-2 with 
escape phage 68 (CEP-68-2). Bacterial strains are unprimed (WT) or primed with 
one (BIM68-1) or two (BIM68-2) spacers matching phage 68. Each bar shows the 
average fraction of phage sensitivity or immunity through CRISPR or sm. Final 
phage 68 concentrations were as follows; 8 x 109 pfu/mL (WT), 2 x 109 pfu/mL 
(BIM68-1) and 1 x 1011 pfu/mL (BIM68-2). Error bars are measured as 95% 
confidence intervals. 
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Figure 3: Diagram of partial match of spacer 1 on the CRISPR2 locus to DMS3vir. 
The spacer is represented on the bottom as crRNACR2_sp1, and phage DMS3vir on 
the top as DMS3-42 T255. The orientation of the locus is simplified by boxing the 
crRNA seed and the phage PAM sequence. Arrows above the DMS3vir sequence 
indicate point mutations enabling evasion of CRISPR-Cas. Image taken from Cady 
et al. 2012. 
 
 
 
4. Discussion 
 
Here I demonstrate that the presence of spacers targeting specific phage sequences 
can enhance the priming process of the CRISPR-Cas system. By first evolving 
engineered Pseudomonas aeruginosa spacer knockout strains, with phage DMS3vir, 
I was able to test the importance of prior spacer sequences on the priming efficiency 
of the CRISPR-Cas system. Spacer removal, or their reduced numbers, resulted in 
host defence system change to sm-mediated resistance. Following this, P. 
aeruginosa bacteriophage insensitive mutants (BIMs) were generated by evolving 
with a novel phage species, phage 68, to test whether increased phage recognition 
would increase priming. In spite of limited spacer acquisition, detection of CRISPR-
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Cas increased. However, the most prevalent means of bacterial resistance was 
mainly evolved through sm.  
 
Studies have shown that the positive feedback loop of priming is greatly influenced 
by the first spacer acquisition event (Datsenko et al. 2012, Swarts et al. 2012) and 
that in comparison to naive adaptation, priming is rapid (Savitskaya et al. 2013). It is 
therefore not surprising that, with spacer removal, P. aeruginosa knockout strains 
showed a distinctive lack of renewed spacer acquisition with DMS3vir infection. The, 
albeit limited, priming observed for CRISPR 2 Δ 2-21 (Figure 1) can be explained by 
the partial match of spacer 1 to DMS3vir (Figure 3). Previous infection of WT cells 
with DMS3vir has been shown to promote high levels of resistance by CRISPR-Cas 
spacer incorporation (Westra et al. 2015). Figure 1 is also qualitatively consistent to 
the evolution experiment conducted in the Westra et al. (2015) study. So, once 
spacer 1 is deleted (CRISPR 2 Δ 1-2, Figure 1), spacer acquisition is removed. This 
is consistent with the theory that spacers play an important role in the process of 
priming (Datsenko et al. 2012, Li et al. 2014, Richter et al. 2014) and when removed, 
will remove the adaptive ability of the CRISPR-Cas system and instead result in host 
defence system change, which in this case was sm-mediated resistance.  
 
It has also been hypothesized that early phage infection history has an important 
effect on the generation of new resistance. However, the data obtained using phage 
68 does not support this. It was believed that once a host had acquired a phage 
derived spacer, the incorporation of additional spacers would occur at a higher 
frequency. Even though renewed CRISPR-Cas resistance is detectable, sm remains 
largely the dominant resistance mechanism. Perhaps the lack of CRISPR-Cas 
resistance is the result of high phage virulence. The lytic lifecycle of phage 68 may 
be too fast for active spacer incorporation to occur, especially with high infection 
titres. Therefore, if virulence is too strong and priming too weak, the host may evolve 
a more costly form of resistance by modifying its surface. 
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The main conclusion is that priming is important in this system. Indeed, immune 
priming is also found to be beneficial in other systems. The bumble bee Bombus 
terrestris, for example, when infected by similar parasites where shown to have 
improved immune system “memory” upon successive parasite challenges (Sadd & 
Schmid-Hempel 2006). In an experiment using the beetle Tenebrio molitor, Moret 
and Siva-Jothy (2003) were able to demonstrate that the survival of pathogen 
infection is greatly increased by previous encounters with pathogens. However, 
increased phage recognition did not increase priming equally between two different 
phage species in this study. It is still puzzling why we observe high levels of 
CRISPR-Cas mediated resistance in P. aeruginosa-DMS3vir interactions and not in 
other P. aeruginosa-phage interactions. Deep sequencing of bacterial populations 
will help to elucidate the result of reduced priming towards phage 68 by showing total 
CRISPR resistance in a population rather than estimating the frequency of total 
evolved adaptive immunity in a subset of individuals, and will thus be conducted in 
future investigation. 
 
 
 
 
 
 
 
 
 
 
 
  61  
  
Chapter 4 
 
The effects of multiple bacteriophage infection on the evolution of CRISPR 
resistance in primed bacterial strains  
 
Abstract 
 
In Chapter 2, I demonstrated how CRISPR-Cas immunity typically fails to evolve 
when Pseudomonas aeruginosa was exposed to mixtures of phages. However, 
bacteria were either naive (unprimed) against all phage species, or primed against 
only a single phage species. Here I investigate whether CRISPR-Cas immunity 
evolves when bacteria are primed prior to infection against all phages involved. To 
this end I use the P. aeruginosa PA14-derived strains described in Chapter 3, primed 
to both phage 68 and DMS3vir. Thereby, exposure to either phage is able to trigger 
host spacer incorporation. Although detectable levels of CRISPR-Cas immunity 
evolve upon exposure to single phages, CRISPR-Cas resistance fails to evolve upon 
mixed infection. This further supports my earlier conclusion that CRISPR-Cas 
consistently fails to evolve when exposed to multiple phages, where the host will 
instead favour the evolution of more broad range resistance mechanisms. Perhaps 
the pressure of multiple parasites on the CRISPR-Cas system is too great for 
efficient resistance to occur by means of spacer incorporation; alternatively, the 
benefit of surface modification could be greater as this confers resistance to both 
phages. 
 
 
1. Introduction 
 
An adaptive immune system is predicted to be beneficial when faced with parasite 
diversity as adaptive immunity is associated with low fitness costs (Horvath & 
Barrangou 2010). However, as described in Chapter 2, adaptive immunity against 
multiple phages consistently fails to evolve. This may be driven by a lack of priming 
against all phages involved in these studies, as priming has been shown to be key to 
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the evolution of CRISPR-Cas immunity in Chapter 3 and other experimental systems 
(Datsenko et al. 2012, Swarts et al. 2012, Finneran et al. 2012, Li et al. 2013, Richter 
et al. 2014).  
 
Priming in the CRISPR-Cas system relies on sequence mismatches between a pre-
existing spacer and a phage proto-spacer, and triggers increased rates of spacer 
acquisition (Datsenko et al. 2012, Fineran & Charpentier 2012, Heler et al. 2014). As 
the CRISPR locus can be considered a library of past infections, spacer sequences 
are not limited to single phage species and presumably offer recognition to a diverse 
set of parasites. Indeed, metagenomic and bioinformatic analyses show that this 
system is adaptive to diverse pathogens (Andersson & Banfield 2008, Horvath et al. 
2008). However, despite priming having been demonstrated to renew resistance to 
an invader, it is not yet firmly established how efficient this system is when multiple 
spacer acquisition events are required, or if it is always the most ideal defence 
system. If a parasite diverse environment contains phage species that target 
different receptors on the host cell surface, then each specific surface modification 
required may be too costly for the host (Koskella et al. 2011), making CRISPR-Cas 
resistance beneficial as it is not dependent on the phages mode of infection. On the 
other hand, if all phages target the same receptor, it may be more beneficial to alter 
the receptor as resistance will be applied against multiple phages. 
 
I have previously shown how parasite diversity induces sm-mediated defence when 
the host is unprimed and infected with mixed phages (Chapter 2). Therefore, this 
chapter investigates whether the CRISPR-Cas system is able to rapidly evolve when 
the host is primed against all phages present in an environment. However, even 
though the host is primed, the phages all target the same host receptor (pili). Thus, 
the prediction is that sm will be the most prevalent resistance mechanism. 
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2. Materials and Methods 
 
2.1 Bacterial strains, phages and media 
 
Bacteria and bacterial growth media 
Pseudomonas aeruginosa wild type (WT) PA14, P. aeruginosa CRISPR-Cas knock-
out strain csy3::LacZ (LacZ), along with bacteriophage insensitive mutants (BIMs) 
described in Table 1 (BIM68-1 and BIM68-2) were used in the following experimental 
procedures. Bacterial growth media is as described in Chapter 1. 
 
Phage 
The rationale and preparation of phage 68 is described in Chapter 3. Sequencing 
analysis showed 100% homogeneity of both BIM-1 and BIM68-2 to phage DMS3vir, 
meaning that the spacer targeting phage 68 also targets phage DMS3vir. Thus, 
DMS3vir escape phages were obtained for both BIMs. A 1:1 mixture of 500µL BIM 
(either BIM68-1 or BIM68-2) and 500µL LacZ cells were inoculated into LB media 
and infected with 104 pfu (plaque forming units)/mL DMS3vir. Chloroform extractions 
were performed on overnight cultures, and plaque assays onto each respective BIM 
bacterial lawn enabled a single CRISPR escape phage plaque (CEP-DMS3vir-1 and 
CEP-DMS3vir-2) for each BIM to be isolated. Plaque assays contained 10µL of 106 
pfu/mL and 300µL of either BIM68-1, or BIM68-2 overnight grown cells which were 
added to 9mL of 0.5% LB agar and poured over 1.5% LB agar. Stock solutions of 
CEP-DMS3vir-1 and CEP-DMS3vir-2 were generated and stored at 4°C. 
 
2.2 Streak assays, phage titrations and spacer acquisition 
The method for streak assays can be found in Chapter 1. In experiments containing 
phage combinations, single colonies were streaked against both phages involved in 
the procedure. 
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Phage titrations were performed as described in Chapter 1. Overall titrations for 
experiments containing phage combinations were noted where phage type was not 
separated.   
Spacer acquisition was measured in the same manner as in Chapter 1. 
 
2.5 Priming experiments 
To test the effect of multiple phages on spacer acquisition, all bacterial strains were 
infected with combinations of phage 68 and DMS3vir. Bacterial strains and phages 
used are described in Table 1. WT strain was infected with ancestral phage 68 and 
DMS3vir, BIM68-1 with CEP-68-1 and CEP-DMS3vir-1, and BIM68-2 with CEP-68-2 
and CEP-DMS3vir-2. Phage 1:1 mixtures were created by combining 500µL of 106 
pfu/mL of each phage, where 104 pfu/mL of the combination was added to ~106 
cfu/mL overnight grown bacterial cultures in 6 replicates of 0.2% glucose M9 media 
and allowed to evolve over a total of three daily transfers in 37°C. 
 
In parallel, and under the same conditions, WT, BIM68-1, and BIM68-2 were infected 
with 104 pfu/mL of ancestral phage 68, CEP-68-1, and CEP-68-2 respectively. Also, 
bacterial strains were infected with ancestral DMS3vir, CEP-DMS3vir-1, and CEP-
DMS3vir-2. Again, these cultures were inoculated, in replicates of 6, into 0.2% 
glucose M9 and transferred into fresh media over three days. 
 
All three evolution experiments were, at 3 days post infection (dpi), diluted into M9 
salts and plated onto 1.5% LB agar. Overnight incubation in 37°C produced single 
colonies, 16 of which for each replicate were randomly picked and re-suspended into 
0.2% glucose M9 for overnight growth. Resistance and mode of resistance, along 
with phage titrations were determined at 3dpi. PCRs were also performed to account 
for any spacer acquisition. 
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Table 1: BIMs and escape phages used in experimental procedures 
 
Bacteriophage 
insensitive mutant 
(BIM) 
Number of 
spacers 
CRISPR Escape 
phage 
Resistant to 
BIM68 – 1 1 
 
CEP-DMS3vir-1 
 
DMS3vir 
 
CEP-68-1 
 
Phage 68 and 
DMS3vir 
BIM68 – 2 2 
 
CEP-DMS3vir-2 
 
DMS3vir 
 
CEP-68-2 
 
Phage 68 and 
DMS3vir 
 
 
 
2.6 Statistical analysis 
Description of statistical packages used can be found in Chapter 1. 
In the interest of determining any significant differences of CRISPR-Cas mediated 
immunity across bacterial strains, Kruskal-Wallis tests were used in statistical 
analysis. To test for significance, all analyses applied α = 0.05. 
 
 
3. Results 
 
To compare the evolution of defence mechanisms between a primed bacterial strain 
and an unprimed bacterial strain, WT Pseudomonas aeruginosa PA14 was infected 
with ancestral phage 68 and DMS3vir, alone and in combination. In agreement with 
previous findings (Chapters 2 and 3), bacteria evolved CRISPR-Cas immunity 
against DMS3vir, but not against phage 68, nor against the combination of both 
(Figure 1). As such, there was a clear significant difference between all phage 
treatments on CRISPR-Cas mediated resistance using WT cells (Kruskal-Wallis: X2 = 
16.25, df = 2, P < 0.001, Figure 1). 
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In order to test the effect of phage diversity on the evolution of defensive 
mechanisms in bacterial strains primed to all phages, BIMs; BIM-68-1 and BIM-68-2 
were infected, singularly, with escape phages 68 and DMS3vir and in combination of 
both. CRISPR-Cas resistance was observed for DMS3vir and phage 68, but not in 
mixtures of both (Figure 2 and Figure 3). As such, CRISPR-Cas resistance was 
significantly different between contrasting phage infections with BIM68-1 (Kruskal-
Wallis: X2 = 13.15, df = 2, P = 0.001, Figure 2) and BIM68-2 (Kruskal-Wallis: X2 = 
12.35, df = 2, P = 0.002, Figure 3). Thus, phage infection(s) had a crucial effect on 
mediated resistance response in P. aeruginosa. This shows that, when bacterial 
strains are primed against both phage species, the mixtures of both phages result in 
fewer spacer acquisitions than when with single infections. 
 
It should be noted that in all mixed phage experiments, CRISPR-Cas mediated 
phage resistance was measured against both phages. Upon mixed infection, some 
spacer acquisition was observed for both BIM68-1 and BIM68-2, but these spacers 
only provided resistance against DMS3vir. Importantly, compared to DMS3vir single 
infection, spacer acquisition in combination was greatly reduced. This shows that 
CRISPR-Cas immunity towards DMS3vir is significantly different when combined 
with phage 68 as opposed to single phage infection (Kruskal-Wallis: X2 = 9.4, df = 2, 
P = 0.009). 
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Figure 1: Average fraction of P. aeruginosa strain PA14 (WT) population immunity 
and sensitivity at 3dpi. The infections were; phage DMS3vir, phage 68, and the 
combination of phage (DMS3vir and phage 68). Immunity is divided into CRISPR-
Cas mediated or sm-mediated. Final phage concentrations averaged to 8 x 107 
pfu/mL (DMS3vir), 8 x 109 pfu/mL (phage 68) and 6 x 1010 pfu/mL (DMS3vir + phage 
68). Error bars are measured as 95% confidence intervals. 
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Figure 2: Average fraction of bacterial strain BIM68-1 population immunity and 
sensitivity at 3dpi. The infections were; escape phage DMS3vir (CEP-DMS3vir-1), 
escape phage 68 (CEP-68-1) and the combination of escape phage (CEP-DMS3vir-
1 and CEP-68-1). Immunity is divided into CRISPR-Cas mediated or sm-mediated. 
Final phage concentrations averaged to 1 x 107 pfu/mL (CEP-DMS3vir-1), 2 x 109 
pfu/mL (CEP-68-1) and 2 x 1010 pfu/mL (CEP-DMS3vir-1 + CEP-68-1). Error bars 
are measured as 95% confidence intervals. 
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Figure 3: Average fraction of bacterial strain BIM68-2 population immunity and 
sensitivity at 3dpi. The infections were; escape phage DMS3vir (CEP-DMS3vir-2), 
escape phage 68 (CEP-68-2), and the combination of escape phage (CEP-DMS3vir-
2 and CEP-68-2). Immunity is divided into CRISPR-Cas mediated or sm-mediated. 
Final phage concentrations averaged to 1 x 1011 pfu/mL (CEP-DMS3vir-2), 5 x 104 
pfu/mL (CEP-68-2) and 2 x 1011 pfu/mL (CEP-DMS3vir-2 + CEP-68-2). Error bars 
are measured as 95% confidence intervals. 
 
 
4. Discussion 
 
Here I show that, despite spacer incorporation occurring with single phage infections 
of primed strains of Pseudomonas aeruginosa PA14, the same strains fail to evolve 
CRISPR-Cas based immunity upon mixed infections. Instead, surface modification 
(sm) was observed to be the most prevalent means of host resistance. Thus 
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complementing the results of Chapter 2 where phage diversity triggered sm-
mediated resistance and not CRISPR-Cas mediated resistance. 
 
Although bacteria consistently failed to evolve CRISPR-Cas immunity against both 
phages during mixed infections, some spacer incorporation was observed. However, 
this was directed exclusively against DMS3vir. This result is interesting as spacer 
acquisition is highly prevalent in single infection of DMS3vir (Westra et al. 2015). Yet, 
when in combination with another phage species, the level of spacer acquisition is 
greatly reduced. This may not be surprising as, according to the mathematical model 
by Weinberger et al. (2012), the chance of rapid spacer acquisition in a parasite 
diverse environment is rare. Reduced CRISPR immunity in experimental conditions 
containing two phages may therefore be accounted for due to the limited chance in 
the simultaneous acquisition of multiple spacers. The pressure imposed by two 
simultaneous phage infections may be too great for the adaptive function of the 
CRISPR-Cas system, and would explain why the evolution of more general 
resistance by surface modification is observed. 
 
As phages are ubiquitous in nature and can outnumber their hosts by tenfold (Suttle 
2005), the probability of encountering multiple different phages is high. Thus, it is 
important to understand how different infections impact the evolution of different host 
defences. These results suggest that CRISPR-Cas mediated resistance is limited in 
the presence of two pilus binding phage. If phage target different receptors, it would 
be reasonable to predict that the multiple alterations of the cell surface binding sites 
necessary for resistance would be too great a cost (Frank 2000) in comparison to 
spacer incorporation by the CRISPR-Cas system. As such, it would be interesting to 
test the effect of bacterial strains primed to both LPS and pilus binding phages, on 
mediated resistance and should thus be the subject for future investigation. 
 
As sm-mediated resistance was observed to be the most prevalent means of 
resistance for P. aeruginosa it would be interesting to understand how the evolution 
of this defence mechanism would affect bacterial virulence in a natural setting. For 
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example, in cystic fibrosis patients, P. aeruginosa relies on biofilm formation to 
spread within its host (Woods et al. 1980). Thus, the loss of pili may reduce disease 
prevalence and limit infection, meaning that phage therapy may benefit from a 
treatment strategy involving phages that target bacterial receptors used for motility. 
In a different system, Pseudomonas syringae relies on pili to infect their host by 
means of adhering to plant leaves. When infected with a pilus-specific 
bacteriophage, P. syringae were found to have a reduced ability to adsorb to leaf 
surfaces due to the loss of their pili (Romantschuk et al. 1993). The importance of 
this structure explains why the adaptive immune system of CRISPR-Cas exists. 
However, it is still unclear as to which selective forces favour one defence 
mechanism over the other, when the CRISPR-Cas system is likely to be activated, 
and whether indeed its sole function lies in host defence. 
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Chapter 5 
 
The diversity-generating benefits of an adaptive immune system 
 
Abstract 
 
Prokaryotic CRISPR-Cas adaptive immune systems insert spacers derived from 
viruses and other parasitic DNA elements into CRISPR loci to provide sequence-
specific immunity (van der Oost et al. 2014, Barrangou et al. 2007). This frequently 
results in high within-population spacer diversity (Andersson & Banfield 2008, Paez-
Espino et al. 2013, Paez-Espino et al. 2015, Westra et al. 2015), but it is unclear if 
and why this is important. Here, we show that as a result of this spacer diversity, 
viruses can no longer evolve to overcome CRISPR-Cas by point mutation, which 
results in rapid virus extinction. This effect arises from synergy between spacer 
diversity and the high specificity of infection, which greatly increases overall 
population resistance. We propose that the resulting short-lived nature of CRISPR-
dependent bacteria-virus coevolution has provided strong selection for the evolution 
of sophisticated virus-encoded anti-CRISPR mechanisms (Bondy-Denomy et al. 
2013). 
 
 
1. Introduction, Results and Discussion 
 
We previously reported that Pseudomonas aeruginosa strain UCBPP-PA14 evolves 
high levels of CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic 
Repeats; CRISPR-associated) adaptive immunity against virus DMS3vir under 
laboratory conditions (Westra et al. 2015). However, viruses can readily evolve to 
overcome sequence specific CRISPR immunity (Deveau et al. 2008, Semenova et 
al. 2011). To study how CRISPR-Cas impacts virus persistence, we measured titres 
of virus DMS3vir over time upon infection of either wild type (WT) P. aeruginosa or a 
functional CRISPR-Cas knock-out (CRISPR KO) strain. Virus that infected the WT 
strain went extinct at 5 days post-infection (dpi) (Figure 1A), whereas virus infecting 
  73  
  
the CRISPR KO strain persisted in all replicates until the experiment was terminated 
at 30 dpi (Figure 1B). WT bacteria exclusively evolved CRISPR-mediated immunity, 
while the CRISPR KO strain evolved immunity by mutation, loss or masking of the 
receptor (i.e. surface mutation) (Extended Data Figure 1). The observation that 
CRISPR-Cas drives virus extinct so rapidly was unexpected since viruses can 
escape CRISPR immunity by a single point mutation (Deveau et al. 2008, Semenova 
et al. 2011). 
 
Virus extinction might result from the high level of spacer diversity that naturally 
evolves upon virus exposure in this and other CRISPR-Cas systems (Andersson & 
Banfield 2008, Paez-Espino et al. 2013, Paez-Espino et al. 2015, Westra et al. 
2015). Both theory and data suggest that host genetic diversity can synergistically 
reduce the spread of parasites if the infection process is specific (i.e. a parasite 
genotype can infect a restricted number of host genotypes) and a failed infection 
results in parasite death (Childs et al. 2014, Lively et al. 2010, King & Lively 2012, 
Van Baalen & Beekman 2006, Altermatt & Ebert 2008, Schmid-Hempel & Crozier 
1999, Levin et al. 2013, Iranzo et al. 2013, Keesing et al. 2010); assumptions that 
hold for CRISPR-Cas-virus interactions. While the protective effect of host diversity 
may be lost following the evolution of single viruses that escape from multiple 
spacers (Childs et al. 2014, Iranzo et al. 2013), host diversity has the additional 
benefit of limiting such viral adaptation. Specifically, lower virus population sizes 
resulting from host diversity (Lively 2010a, King & Lively 2012) reduce the probability 
of escape mutations, and the greater the diversity the more escape mutations 
needed.  
 
To examine these hypotheses, we generated bacterial populations in which we 
manipulated the level of spacer diversity; we used 48 individual clones with CRISPR-
based immunity against virus DMS3vir to generate bacterial populations with five 
distinct diversity levels: monocultures or polycultures consisting of equal mixtures of 
either 6, 12, 24 or 48 clones. To allow for direct comparisons, each of the 48 clones 
was equally represented at each diversity level by adjusting the number of replicate 
experiments accordingly. Each population was competed against a previously 
  74  
  
described surface mutant (Westra et al. 2015) in the presence or absence of virus 
DMS3vir and virus levels were monitored over time. 
 
This experiment revealed a strong inverse relationship between virus persistence 
and the level of spacer diversity in the bacterial population (Figure 2). Virus titers 
remained high in 44 out of 48 replicates when the CRISPR population consisted of a 
monoculture (Figure 2A). However, as diversity increased, virus persistence 
decreased (Figures 2B-E) and virus was driven extinct rapidly and reproducibly when 
the CRISPR population consisted of a 48-clone mixture (Figure 2E). 
 
Next, we examined the fitness consequences of generating spacer diversity. In the 
absence of virus there was no significant effect of diversity on the relative fitness 
associated with CRISPR-Cas compared to a resistant surface mutant (Extended 
Data Figure 2; F1, 52=3.20, p=0.08). However, in the presence of virus CRISPR-
associated fitness increased with increasing spacer diversity (Figure 3; F4,71=40.30 
p<0.0001 and Extended Data Table 1), with mean fitness increasing 11-fold from 
monoculture to the highest diversity population. In monoculture, the CRISPR 
population was outcompeted by the surface mutant (rel. fitness < 1; T=-11.68, 
p<0.0001). However, as diversity increased, the CRISPR population consistently 
outcompeted the surface mutant (rel. fitness > 1; 6-clones: T=3.05, p=0.0093; 12-
clones: T=3.95, p=0.0028; 24-clones: T=3.48, p=0.0088; 48-clones: T=3.06, 
p=0.014; all significant after sequential Bonferroni correction), showing that the 
generation of spacer diversity is an important fitness determinant of CRISPR-Cas 
(Figure 3).  
 
Given that all bacterial clones used in the experiment were initially resistant, we 
hypothesized that the benefit of spacer diversity emerges from an inability of virus to 
evolve escape mutants. To examine this, virus isolated from each time point (0, 16, 
24, 40, 48, 64 and 72 hours post-infection) was spotted onto lawns of each of the 48 
CRISPR clones. As expected, we could not detect escape virus in the ancestral virus 
(Figure 4A; left column, indicated in green). However, in 43 of the 48 CRISPR 
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monocultures, virus evolved within 2 days to overcome CRISPR immunity (Figure 
4A; indicated in red). For 5 clones no escape virus could be detected, and virus went 
extinct in 4 of these instances (Figure 4A, asterisks). Three of these 5 clones carried 
multiple spacers targeting the virus, which limits the emergence of escape virus 
(Levin et al. 2013). The emergence of escape virus decreased as diversity increased 
to 6, 12, 24 and 48 CRISPR alleles (Figure 4); in the latter, no escape virus could be 
detected. These phenotypic data were supported by results of deep sequencing of 
virus genotypes isolated from 1 dpi: there was a significant inverse relationship 
between host diversity and the accumulation of viral mutations in the target 
sequences (Extended Data Figure 3). This is because virus needs to overcome 
multiple spacers in the diverse host population if it is to increase in frequency 
(Extended Data Figure 4). Consistent with a lack of escape virus emerging against 
all host genotypes, the spacer content of mixed populations of 6, 12, 24 and 48 
clones did not increase between t=0 and t=3 (Wilcoxon Signed Rank p>0.2 for all 
treatments), whereas monocultures acquired novel spacers in response to emerging 
escape virus (Wilcoxon Signed Rank W=333, DF=47, p<0.0001; Extended Data 
Figure 5). These data show that while escape viruses can clearly evolve against 
most of the clones, escape viruses do not emerge when these clones are mixed.  
 
We hypothesized that the benefit of within-population spacer diversity is because of 
synergy between the different clones. However, diversity will also increase the 
chance that a single clone with one or more spacers that the virus is unable to 
overcome will be present in the population. Indeed, we observed 5 clones against 
which escape mutants were never detected, and presence of these clones in many 
of the diverse populations could explain the fitness advantage of diversity. To 
investigate if synergy plays an important role in the benefit of diversity beyond this 
“jackpot” effect, we compared the fitness of diverse populations with the fitness of 
the fittest constituent clone, as measured in monoculture. This analysis revealed that 
synergism contributed an approximately 50% growth rate advantage when in 
competition with surface mutants (Mean ± SEM difference in fitness between 
mixtures and fittest constituent monoculture = 0.47 ± 0.18; P < 0.01). 
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The short-lived nature of coevolution between CRISPR-resistant bacteria and virus 
escape mutants beyond a host diversity threshold may explain the evolution of 
sophisticated anti-CRISPR mechanisms to overcome CRISPR-Cas (Bondy-Denomy 
et al. 2013). Indeed, a virus carrying an anti-CRISPR gene (Bondy-Denomy et al. 
2013) was found to persist independent of CRISPR diversity levels (Extended Data 
Figures 6A-B) and caused similar extinction of CRISPR-resistant monocultures and 
48-clone populations that competed against a surface mutant (Fisher’s exact test, 
p=1.0 at t=1, p=0.33 at t=3 dpi; Extended Data Figure 6C). 
 
Finally, to test that our results were not limited to the P. aeruginosa PA14 Type I-F 
CRISPR-Cas system, we performed a similar experiment with Streptococcus 
thermophilus DGCC7710 clones that evolved resistance against virus 2972 using a 
Type II-A CRISPR-Cas system. As shown in Extended Data Figure 7, we found a 
similar effect of CRISPR resistance allele diversity on virus persistence and escape 
virus emergence. However, during coevolution experiments the levels of evolved 
diversity are lower in S. thermophilus (data not shown and Paez-Espino et al. 2013, 
and Paez-Espino et al. 2015), which, consistent with theory (Childs et al. 2014, 
Iranzo et al. 2013), allows for more persistent coevolution (Paez-Espino et al. 2013, 
Paez-Espino et al. 2015). Lower levels of evolved spacer diversity might be due to a 
more weakly primed CRISPR-Cas system (Datsenko et al. 2012, Swarts et al. 2012, 
Fineran et al. 2014). 
 
Collectively, our data demonstrate that the propensity to generate host genetic 
diversity is a key fitness determinant of CRISPR-Cas adaptive immune systems 
because it limits the emergence of escape virus. Consistent with the idea that it is 
harder for a parasite to adapt to a heterogeneous host population (Hamilton et al. 
1990), virus rapidly evolved high levels of infectivity on monocultures, but not on a 
diverse mix of the same host genotypes. Parasites are often invoked as the selective 
force driving the evolution of diversity generating mechanisms (Hamilton et al. 1990, 
Pal et al. 2007, Morran et al. 2011, Howard & Lively 1994, Ashby & King 2015). In 
most cases, individual-level selection is assumed to be the driver of these traits, 
because individual benefits are high, and group selective benefits would be opposed 
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by the invasion of individuals who do not pay the fitness costs associated with these 
mechanisms (e.g. sex and increased mutation rates) (Ashby & King 2015, Lively 
2010b, Peters & Lively 1999). In the case of CRISPR-Cas, we speculate that 
population-level selection may have contributed to its evolution. First, there were 
large benefits associated with synergy between diverse genotypes. Second, costs of 
CRISPR-Cas are conditional on virus exposure (Westra et al. 2015, Vale et al. 2015) 
and clones lacking CRISPR immunity cannot invade populations (Extended Data 
Figures 8-11). Third, the highly structured nature of bacterial populations, and the 
resulting high relatedness, promotes between-population selection (Gardner & 
Grafen 2009). Future tests of this hypothesis are needed to reconcile the selective 
forces that have shaped the evolution of CRISPR-Cas systems. 
 
 
 
 
Figure 1: Evolution of CRISPR-mediated immunity leads to rapid extinction of virus. 
Titre (pfu/ml) of virus DMS3vir over time upon infection of A) WT P. aeruginosa and 
B) P. aeruginosa strain csy3::LacZ (CRISPR KO strain). Each line indicates an 
individual replicate experiment (n=6). The limit of detection is 200 pfu/mL. 
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Figure 2: Virus persistence inversely correlates with the level of spacer diversity. 
Virus titres (pfu/ml) over time upon infection of a bacterial population consisting of an 
equal mixture of a surface mutant and A) a monoculture with CRISPR-mediated 
immunity (n=48), or polycultures with CRISPR-mediated immunity consisting of B) 6 
clones (n=8), C) 12 clones (n=8), D) 24 clones (n=6), E) 48 clones (n=6). The 
number of replicates is chosen such that all clones are equally represented in each 
treatment. Each line indicates an individual replicate experiment. The limit of 
detection is 200 pfu/ml. 
 
 
 
 
 
Figure 3: Relative fitness of bacterial populations with CRISPR-mediated immunity 
positively correlates with increasing spacer diversity. Relative fitness of bacterial 
populations with CRISPR-mediated immunity, with spacer diversity as indicated, at 3 
days post infection when competing with a surface mutant. Error bars indicate 95% 
confidence intervals. 
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Figure 4: Emergence of virus that overcomes host CRISPR immunity (escape virus) 
during the experiment shown in Figures 2 and 3. Each column in a table represents 
a time point where virus was isolated (0. 16, 24, 40, 48, 64 and 72 hours post 
infection, as indicated below the table (in days post infection)). Green: no escape 
virus. Red: escape virus. Panels A-E correspond to each of the experiments shown 
in Figure 2 A-E. Bold numbers indicate replicate experiments. Numbers between 
parentheses indicate the identity of the clones that are present in the CRISPR 
population. Asterisks indicate that virus went extinct during the experiment. 
 
2. Material and Methods 
 
Bacterial strains and viruses 
P. aeruginosa UCBPP-PA14 (WT), P. aeruginosa UCBPP-PA14 csy3::LacZ 
(referred to as CRISPR KO, which carries a disruption of an essential cas gene and 
can therefore not evolve CRISPR immunity), the CRISPR KO-derived surface 
mutant and virus DMS3vir have all been described in Westra et al. (2015) and 
references therein. Phage DMS3vir+acrF1, which carries the anti-CRISPR gene 
acrF1 (formerly 30-35), was made by inserting acrF1 into the DMS3vir genome using 
methods described in Bondy-Denomy et al. (2013). Streptococcus thermophilus 
strain DGCC7710 and its virus 2972 has been described in Barrangou et al. (2007). 
 
Coevolution experiments 
The coevolution experiments shown in Figure 1 were performed in glass microcosms 
by inoculating 6 ml M9 supplemented with 0.2% glucose with approximately 106 
colony forming units (cfu) bacteria from fresh overnight cultures of the WT P. 
aeruginosa UCBPP-PA14 or CRISPR KO strain and adding 104 plaque forming units 
(pfu) of virus DMS3vir, followed by incubation at 37 ºC while shaking at 180 rpm (6 
replicates). Cultures were transferred daily 1:100 to fresh broth. Virus titers were 
determined at 0, 3, 5, 11, 17, 22 and 30 days after the start of the coevolution 
experiment by spotting virus samples isolated by chloroform extraction on a lawn of 
CRISPR KO bacteria. The analysis of virus immunity was performed by cross-streak 
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assay and PCR as described previously (Westra et al. 2015).  
 
Generation of populations with different levels of CRISPR diversity 
For the competition experiments, shown in Figures 2-4 and Extended Data Figures 
2-6 and 8-11, we generated P. aeruginosa populations with varying levels of 
CRISPR spacer (allele) diversity. To this end, we isolated from the 6 replicates of the 
coevolution experiment (Figure 1) a total of 48 individual clones that had acquired 
CRISPR immunity against virus DMS3vir. We have previously shown that individual 
clones tend to have unique spacers (Westra et al. 2015). Using these 48 clones, 
populations with five different levels of CRISPR spacer (allele) diversity were 
generated. These populations consisted of: 1) 1 clone (a monoculture; a clonal 
population carrying a single spacer); equal mixtures of 2) 6 clones; 3) 12 clones; 4) 
24 clones and 5) 48 clones. In total 48 different monocultures (48 x monocultures), 8 
x 6-clone populations, 4 x 12-clone populations, 2 x 24-clone populations and 1 x 48-
clone population were generated (details of the composition of each population can 
be found below, under “number of replicate experiments”).  
 
Competition experiments 
Competition experiments were done in glass microcosms in a total volume of 6 ml 
M9 supplemented with 0.2% glucose. Competition experiments were initiated by 
inoculating 1:100 from a 1:1 mixture (in M9 salts) of overnight cultures of the 
appropriate CRISPR population and either the surface mutant (Figures 2-4 and 
Extended Data Figures 2, 4-6, 8) or the CRISPR KO strain (Extended Data Figures 
7-11). At the start of each experiment 109 pfu of virus was added, unless indicated 
otherwise. Cultures were transferred daily 1:100 into fresh broth. At 0 and 72 hours 
post-infection (hpi) samples were taken and cells were serially diluted in M9 salts 
and plated on LB agar supplemented with 50 μg.ml-1 X-gal (to allow discrimination 
between WT-derived CRISPR clones (white) and CRISPR KO or surface mutant 
(blue)). The relative frequencies of the WT strain were used to calculate the relative 
fitness (rel. fitness = [(fraction strain A at t=x) * (1 – (fraction strain A at t=0))] / 
[(fraction strain A at t=0) * (1 – (fraction strain A at t=x)]). At 0, 16, 24, 40, 48, 66 and 
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72 hpi, samples were taken and chloroform extractions were performed to isolate 
total virus, which was spotted on a lawn of CRISPR KO bacteria for quantification. All 
subsequent statistical analyses were carried out using JMP (v12) software. 
 
Determination of escape virus emergence 
To determine the emergence of escape virus during the competition experiments, 
every isolated virus sample was spotted onto 48 different bacterial lawns, 
corresponding to each of the different CRISPR clones. This procedure was done for 
each of the seven time points (see above), to enable us to track the emergence of 
escape virus against every individual clone over the time course of the experiment.  
 
Deep sequencing 
Isolated phage samples from t=1 dpi of the competition experiment shown in Figures 
2-4 were used to perform deep sequencing of spacer target sites on the phage 
genomes. To obtain sufficient material, phage were amplified by plaque assay on the 
CRISPR KO strain. Viruses from all replicates within a single diversity treatment 
were pooled. As a control, ancestral virus and escape virus from competition 
between sm and monocultures of CRISPR clones 1-3 were processed in parallel. 
Virus genomic DNA extraction was performed from 5 ml sample at approximately 
1010 pfu/ml using the Norgen phage DNA isolation kit, following the manufacturer’s 
instructions. Barcoded Illumina Truseq Nano libraries were constructed from each 
DNA sample with an approximately 350bp insert size and 2x 250bp reads generated 
on an Illumina MiSeq platform. Reads were trimmed using Cutadapt v1.2.1 and 
Sickle v1.200 and then overlapping reads merged using Flash v1.2.8 to create high 
quality sequence at approximately 8000x coverage of DMS3vir per sample. These 
reads were mapped to PA14 and DMS3vir genomes using bwa mem v0.7.12 and 
allele frequencies of SNPs within viral target regions quantified using samtools 
mpileup v0.1.18. Further statistical analyses were performed in R v3.2.2. Sequence 
data are available from the European Nucleotide Archive under accession 
PRJEB12001 and analysis scripts are available from 
https://github.com/scottishwormboy/vanHoute. 
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Determining the acquisition of new spacers 
To examine spacer acquisition during the competition experiments shown in Figures 
2-4, we examined by PCR for each diversity treatment the spacer content of 384 
randomly isolated clones at both t=0 and t=3 (192 clones per time point). For each 
replicate experiment, the difference in the total number of spacers between t=0 and 
t=3 was divided by the number of clones that were examined to calculate the 
average change in the number of spacers per clone. 
 
Number of replicate experiments 
To ensure equal representation of each of the 48 clones across the different 
treatments, the number of replicate experiments for a given diversity treatment was 
adjusted accordingly, with a total number of replicates of at least 6 for sufficient 
statistical power. Hence, competition experiments with the 1-clone (monoculture) 
populations were performed in 48 independent replicates, each corresponding to a 
unique monoculture of a CRISPR clone (clones 1-48; each clone is equally 
represented). Competition experiments with the 6-clone populations were performed 
in eight independent replicates, each corresponding to a unique polyculture 
population (population 1: equal mixture of clones 1-6; population 2: clones 7-12; 
population 3: clones 13-18; population 4: clones 19-24; population 5: clones 25-30; 
population 6: clones 31-36; population 7: clones 37-42; population 8: clones 43-48). 
Competition experiments with the 12-clone populations were also performed in eight 
replicates, corresponding to 4 unique polyculture populations (replicate 1 and 2: 
clones 1-12; replicate 3 and 4: clones 13-24; replicate 5 and 6: clones 25-36; 
replicate 7 and 8: clones 37-48). Competition experiments with the 24-clone 
populations were performed in six replicates, corresponding to 2 unique polyculture 
populations (replicate 1-3: clones 1-24; replicate 4-6: clones 25-48). Competition 
experiments with the 48-clone populations were performed in six replicates, each 
corresponding to the same polyculture population (replicate 1-6: clones 1-48).  
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Escape phage degradation and fitness 
In the experiment shown in Extended Data Figure 3, approximately 108 pfus of either 
ancestral virus or escape virus, which was isolated from the competitions between 
monocultures 1-6 and the surface mutant, was used to infect a monoculture of the 
corresponding CRISPR clone or the 48-clone polyculture. Phage samples were 
taken at 0, 9, 20 and 28 hpi by chloroform extraction and titrated on a lawn of the 
CRISPR KO strain. Fitness of each of the escape phages was determined by a 
competition experiment between ancestral and escape virus; a 50:50 ratio of escape 
and ancestral phage (109 pfus total) was used to infect either a monoculture of the 
corresponding CRISPR clone or the 48-clone polyculture. Virus samples were taken 
at t=0 and t=20 hpi by chloroform extraction and used in a plaque assay on CRISPR 
KO. Next, individual plaques (48 plaques per replicate) were isolated and amplified 
on the CRISPR KO strain. To determine the ratio of escape and ancestral virus, virus 
from each individual plaque was spotted on a lawn of 1) CRISPR KO (both ancestral 
and escape virus form plaques) and 2) the corresponding CRISPR immune clone 
(only escape virus can form a plaque).  
 
Effect of spacer diversity in Streptococcus thermophilus  
Streptococcus thermophilus DGCC7710 was grown in M17 medium supplemented 
with 0.5% α-lactose (LM17) at 42°C. Virus 2972 was used throughout the 
experiments. Virus infections were carried out using 106 pfus of phage 2972 and 
10mM CaCl2 to facilitate the infection process. To obtain virus-resistant S. 
thermophilus clones, a sample of virus lysate at 24 hpi was plated on LM17 agar 
plates. Individual colonies were picked and PCR-screened for the acquisition of 
novel spacers in each of the 4 CRISPR loci, as described in Barrangou et al. (2007). 
A total of 44 individual clones were selected to generate 44 monocultures and a 
single polyculture comprised of a mix of 44 clones. These cultures were infected with 
107 pfu of virus, and samples were taken after the indicated periods of time to isolate 
virus. We determined virus titres by spotting viral dilutions on lawns of ancestral 
bacteria, and the emergence of escape virus by spotting virus on lawns 
corresponding to each of the 44 CRISPR resistant clones. 
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Figure 4: Emergence of virus that overcomes host CRISPR immunity (escape virus) 
during the experiment shown in Figures 2 and 3. Each column in a table represents 
a time point where virus was isolated (0, 16, 24, 40, 48, 64 and 72 hours post-
infection, as indicated below the table (in days post-infection)). Green: no escape 
virus. Red: escape virus. Panels A-E correspond to each of the experiments shown 
in Figure 2 A-E. Bold numbers indicate replicate experiments. Numbers between 
parentheses indicate the identity of the clones that are present in the CRISPR 
population. Asterisks indicate that virus went extinct during the experiment. 
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General discussion 
 
In the face of pathogen infection, hosts have evolved a wide array of defence 
mechanisms. In particular, bacteria can adapt to threats using at least five different 
mechanisms within the ranges of intracellular and extracellular defences, from 
surface modification, the restriction modification system, abortive infection, and 
invader uptake block to the CRISPR-Cas system. While the molecular mechanisms 
of these immune strategies have been explored in great detail, there is limited 
knowledge about which selective forces favour one mechanism over the other. A 
recent study revealed how the risk of infection can drive the evolution of constitutive 
(surface modification) versus inducible (CRISPR-Cas) defences (Westra et al. 2015). 
While co-evolution experiments between a single bacterial species and single lytic 
phages are crucial for examining elicited immune responses, they tell us little about 
host defence evolution in a natural setting where phage diversity may exist.  
 
This thesis has endeavoured to understand the effects of different phage conditions 
on the evolution of the CRISPR-Cas system in the pathogenic bacterial host 
Pseudomonas aeruginosa. Although it is not conclusive, I provide novel evidence 
that bacteria primed to multiple phages, will not necessarily continue to prime in 
parasite diverse conditions (Chapter 4). Indeed, by exploring naive (Chapter 2) as 
well as primed bacteria (Chapter 4), I found that increased phage diversity 
consistently favoured the evolution of surface modification based resistance. 
Understanding the evolution of this defensive mechanism is important as the 
implications that result from the modifications to cell surfaces affect the bacteria’s 
ability to colonize and infect its host. P. aeruginosa adherence to the human upper 
respiratory epithelium of cystic fibrosis patients is mediated through pili and allows 
the formation of biofilms which are fundamental in the spread of infection (Woods et 
al. 1980, O’Toole & Kolter 1998). Thus, the loss or modification of this structure will 
affect disease spread. Therefore, the application of phages that trigger pili loss 
could, potentially, be useful in developing new methods of phage therapy in biofilm 
forming bacterial pathogens.  
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Host resistance by surface modification or CRISPR-Cas have different implications 
for both ecological and evolutionary interactions between bacteria and phage. 
Specifically, we have shown how phage persists in conditions where host 
populations evolve resistance by surface modification, whilst being rapidly driven 
extinct when bacteria evolve CRISPR-Cas immunity (Chapter 5). This effect 
emerges from the high levels of CRISPR allele diversity that naturally evolves in 
initially clonal populations, making it harder for phage to overcome host resistance 
due to the number of diverse host genotypes. We have been able to demonstrate 
that, where bacterial monocultures suffer high parasite infectivity, with increasing 
CRISPR polycultures, parasite evolution is limited and eventually driven extinct. This 
highlights the importance of the production of genetic diversity in increasing herd 
immunity and decreasing the spread of disease (King & Lively 2012); a concept 
which has been demonstrated in crop management where genetically diverse rice 
crops limit the severity of rice blast disease outbreak in comparison to genetically 
homogenous crops (Zhu et al. 2000).  
 
Little is known about what conditions favour CRISPR-Cas systems in nature. 
However, we know that priming is important in the P. aeruginosa - bacteriophage 
system (Chapter 3) as well as in other systems (Datsenko et al. 2012, Li et al. 2013, 
Richter et al. 2014). As priming is important, relatedness between phages is 
advantageous to the bacterial host. Spacers targeting one phage species may, in 
some cases, offer partial matches to related phage species. As a result, rapid spacer 
acquisition will occur to the related phage species (Andersson & Banfield 2008). This 
leads to the speculation that CRISPR-Cas systems may be favoured in spatially 
structured environments as it produces high levels of spacer diversity (Chapter 5, 
Haerter & Sneppen 2012). High relatedness between locally adapted phages means 
that diversity generated by the CRISPR-Cas system will be beneficial to the local 
host. This is shown in Chapter 5 with CRISPR driving the local phage population to 
extinction. Harsh environmental conditions, such as acid mine drainage sites, could 
also favour the evolution of CRISPR-Cas immunity due to low population densities 
and limited species richness of both hosts and phages (Baker & Banfield 2003). 
Indeed, these environments allow for more intense host-parasite interactions. As 
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such, metagenomic analyses of biofilms forming these communities reveal active 
CRISPR-Cas evolution (Denef et al. 2010). 
 
In conclusion, my thesis has aimed to draw attention to the different effects that 
familiar, novel, and diverse phage populations have on shaping the evolution of 
resistance in their bacterial host. While research into the molecular biology of the 
CRISPR-Cas system is booming, there is little understanding of what environmental 
factors affect the evolution of this defence strategy. The knowledge of how multiple 
pathogens can affect the evolution of host defence strategies is still limited, and 
continued research is vital in light of the development of therapeutic application of 
phages to reduce the spread of bacterial disease (Debarbieux et al. 2009). Finally, 
the importance of priming as well as naive resistance will help to establish how often, 
and under what conditions, CRISPR-Cas is mediated in natural environments. 
Further investigation into the ecological pressures responsible for the evolution of 
CRISPR-Cas immunity could ultimately lead to a greater understanding of host-
parasite arms races. 
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Appendix 
 
Extended data Chapter 5 
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Extended data Figure 1: Infection with virus DMS3vir leads to rapid evolution of 
CRISPR-mediated immunity in WT bacteria, while CRISPR KO bacteria primarily 
evolve virus immunity by surface mutation. Percentage bacteria at 5 days post-
infection that have evolved immunity by CRISPR-Cas (white bar), surface mutation 
(black bar) or that have not evolved immunity (sensitive; grey bars). Error bars 
indicate 95% confidence intervals (CI). 
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Extended data Figure 2: No benefit of increasing spacer diversity in the absence of 
virus. Relative fitness of CRISPR immune monocultures (single spacer; low diversity) 
and polycultures (48 spacers; high diversity) at 3 days post-infection when 
competing with a surface mutant (sm) in the absence of virus. Error bars indicate 
95% CI. 
 
  94  
  
 
 
Extended data Figure 3: Deep sequencing analysis of the frequency of mutations in 
the target sequence (seed sequence and the adjoining PAM) of virus isolated at t=1 
from the experiment shown in Figure 4. A) Frequency of point mutation in the single 
target sequence of a viral population isolated from the monocultures of clones 1-3. 
B) Average frequency of point mutation across all target sites in the ancestral virus 
genome and in the genomes of virus from pooled samples of all replicates from a 
single diversity treatment. Error bars indicate 95% (CI). 
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Extended data Figure 4: Escape virus titres decline upon infection of diverse 
CRISPR populations despite increased fitness over ancestral virus. Escape virus 
was isolated from monocultures of clones 1-6 competing with the surface mutant at 
24 hpi (Figure 3 and Extended Data Figure 2). A) Virus titres (pfu/ml) over time upon 
infection with approximately 107 pfu individual escape virus or ancestral virus of a 
bacterial population consisting of a monoculture (dotted line) or 48-clone polyculture 
(solid line). B) Relative fitness of escape virus and ancestral virus during infection of 
a CRISPR resistant monoculture or polycultures consisting of 48 clones. All 
experiments were performed in 6 replicates. Error bars indicate 95% CI. The limit of 
detection is 200 pfu/ml. 
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Extended data Figure 5: Diverse populations do not acquire additional spacers 
during the experiments shown in Figures 2-4. For each diversity treatment we 
examined the spacer content of 192 randomly isolated clones at both t=0 and t=3 
(384 clones in total per diversity treatment). The change in the total number of 
spacers between t=0 and t=3 was calculated independently for each replicate 
experiment and divided by the number of clones that were examined. The graph 
indicates the average across the replicates of the change in spacer content per clone 
and error bars indicate 95% CI. 
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Extended data Figure 6: Persistence of phage that encodes an anti-CRISPR gene 
is independent of spacer diversity. A) Virus titres (pfu/ml) over time upon infection of 
a bacterial population consisting of an equal mixture of a surface mutant and A) a 
monoculture with CRISPR-mediated immunity (n=48) or B) a 48-clone polyculture 
with CRISPR-mediated immunity (n=6). Each clone is equally represented in each 
treatment. Each line indicates an individual replicate experiment. The limit of 
detection is 200 pfu/ml. C) The number of replicate experiments in which the 
CRISPR immune population went extinct (no detectable white colonies) at 1 and 3 
dpi. 
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Extended data Figure 7: Virus persistence inversely correlates with the level of 
CRISPR spacer diversity in CRISPR immune populations of Streptococcus 
thermophilus. Virus titres (pfu/ml) over time upon infection of a bacterial population 
consisting of A) a monoculture with CRISPR-mediated immunity (n=44) or B) 44-
clone polycultures with CRISPR-mediated immunity (n=28). Each clone is equally 
represented in each treatment. Each line indicates an individual replicate 
experiment. The limit of detection is 200 pfu/ml. C) OD600 of monocultures and 
polycultures at 1 and 2 days post infection. Error bars indicate 95% confidence 
intervals. D) Emergence of virus mutants that overcome CRISPR-mediated immunity 
after 0, 16, and 24 hours post-infection. Green indicates no escape virus. Red 
indicates emergence of escape virus. All polyculture experiments showed no escape 
virus. 
 
 
Extended data Figure 8: Sensitive bacteria are unable to invade bacterial 
populations with CRISPR-mediated immunity in the presence of virus. Relative 
fitness of CRISPR populations with indicated spacer diversity at 3 days post-infection 
when competing with the sensitive CRISPR KO strain. Relative fitness of CRISPR 
populations decreases with increasing spacer diversity due to the rapid virus 
extinction, which benefits sensitive bacteria, but is higher than 1 in all cases. Error 
bars indicate 95% CI. 
  100  
  
 
 
  101  
  
Extended data Figure 9: Virus persistence inversely correlates with the level of 
CRISPR spacer diversity during competition between CRISPR immune populations 
and the sensitive CRISPR KO strain. Virus titres (pfu/ml) over time upon infection of 
a bacterial population consisting of an equal mixture of a CRISPR KO clone and A) a 
monoculture with CRISPR-mediated immunity (n=48), or polycultures with CRISPR-
mediated immunity consisting of B) 6 clones (n=8), C) 12 clones (n=8), D) 24 clones 
(n=6), E) 48 clones (n=6). The number of replicates is chosen such that all clones 
are equally represented in each treatment. Each line indicates an individual replicate 
experiment. The limit of detection is 200 pfu/ml. 
  102  
  
 
 
  103  
  
Extended data Figure 10: Emergence of virus mutants that overcome CRISPR-
mediated immunity during the experiment shown in Extended Data Figure 9. Each 
column in a table represents a time point (0, 16, 24, 40, 48, 64 and 72 hours post-
infection, as indicated below the table (in days post-infection)) where virus was 
isolated. Green indicates no escape virus. Red indicates emergence of escape virus. 
Panels A-E correspond to each of the experiments shown in Extended Data Figure 9 
A-E. Bold numbers indicate replicate experiments. Numbers between parentheses 
indicate the identity of clones that are present in a population with CRISPR-mediated 
immunity. Asterisks indicate replicate experiments where virus went extinct during 
the experiment. 
 
 
Extended data Figure 11: Sensitive bacteria are unable to invade bacterial 
populations with CRISPR-mediated immunity in the absence of virus, independent of 
the level of spacer diversity. Relative fitness of monoculture (single spacer; low 
diversity) and polyculture (48 spacers; high diversity) at 3 days post-infection when 
competing with the CRISPR KO strain (sensitive) in the absence of virus. Error bars 
indicate 95% CI. 
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